<SEC-DOCUMENT>0001193125-24-053163.txt : 20240229
<SEC-HEADER>0001193125-24-053163.hdr.sgml : 20240229
<ACCEPTANCE-DATETIME>20240229150354
ACCESSION NUMBER:		0001193125-24-053163
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		23
CONFORMED PERIOD OF REPORT:	20240226
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240229
DATE AS OF CHANGE:		20240229

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GOODYEAR TIRE & RUBBER CO /OH/
		CENTRAL INDEX KEY:			0000042582
		STANDARD INDUSTRIAL CLASSIFICATION:	TIRES AND INNER TUBES [3011]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				340253240
		STATE OF INCORPORATION:			OH
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-01927
		FILM NUMBER:		24702986

	BUSINESS ADDRESS:	
		STREET 1:		200 INNOVATION WAY
		CITY:			AKRON
		STATE:			OH
		ZIP:			44316
		BUSINESS PHONE:		330-796-2121

	MAIL ADDRESS:	
		STREET 1:		200 INNOVATION WAY
		CITY:			AKRON
		STATE:			OH
		ZIP:			44316
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d776927d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:gt="http://corporate.goodyear.com/20240226" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2024-02-26_to_2024-02-26">GOODYEAR TIRE &amp; RUBBER CO /OH/</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2024-02-26_to_2024-02-26" id="ixv-312">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2024-02-26_to_2024-02-26">0000042582</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="gt-20240226.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2024-02-26_to_2024-02-26"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000042582</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-02-26</xbrli:startDate> <xbrli:endDate>2024-02-26</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">Form <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2024-02-26_to_2024-02-26" id="ixv-323">8-K</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Current Report</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported):&#8194;<span style="font-family:Times New Roman; font-size:1pt">(</span><ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2024-02-26_to_2024-02-26" format="ixt:datemonthdayyearen" id="ixv-324">February 26, 2024</ix:nonNumeric><span style="font-family:Times New Roman; font-size:1pt">)</span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:1pt; font-family:Times New Roman;text-align:center"><span style="color:#fcfcfc"><span style="font-weight:bold">Month 1, 2024 </span></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">THE GOODYEAR TIRE &amp; RUBBER COMPANY</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2024-02-26_to_2024-02-26" format="ixt-sec:stateprovnameen" id="ixv-325">Ohio</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2024-02-26_to_2024-02-26" id="ixv-326">1-1927</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2024-02-26_to_2024-02-26" id="ixv-327">34-0253240</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(State or other jurisdiction<br/>of incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Commission<br/>File Number)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2024-02-26_to_2024-02-26" id="ixv-328">200 Innovation Way</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2024-02-26_to_2024-02-26" id="ixv-329">Akron</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2024-02-26_to_2024-02-26" format="ixt-sec:stateprovnameen" id="ixv-330">Ohio</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2024-02-26_to_2024-02-26" id="ixv-331">44316-0001</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2024-02-26_to_2024-02-26" id="ixv-332">(330)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2024-02-26_to_2024-02-26" id="ixv-333">796-2121</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2024-02-26_to_2024-02-26" format="ixt-sec:boolballotbox" id="ixv-334">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2024-02-26_to_2024-02-26" format="ixt-sec:boolballotbox" id="ixv-335">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2024-02-26_to_2024-02-26" format="ixt-sec:boolballotbox" id="ixv-336">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2024-02-26_to_2024-02-26" format="ixt-sec:boolballotbox" id="ixv-337">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br/>on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-02-26_to_2024-02-26" id="ixv-338">Common Stock, Without Par Value</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-02-26_to_2024-02-26" id="ixv-339">GT</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2024-02-26_to_2024-02-26" format="ixt-sec:exchnameen" id="ixv-340">The Nasdaq Stock Market LLC</ix:nonNumeric></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2024-02-26_to_2024-02-26" format="ixt-sec:boolballotbox" id="ixv-341">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act. &#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;5.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On February&#160;26, 2024, the Human Capital and Compensation Committee of the Board of Directors of The Goodyear Tire &amp; Rubber Company approved forms of grant agreements under the 2022 Performance Plan for non-qualified stock options, non-qualified stock options with tandem stock appreciation rights, performance shares, cash-based performance units and restricted stock units. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:3%"/>
<td style="width:94%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d776927dex101.htm">Form of Non-Qualified Stock Option Grant Agreement </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d776927dex102.htm">Form of Non-Qualified Stock Option with tandem Stock Appreciation Right Grant Agreement </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d776927dex103.htm">Form of Performance Share Grant Agreement </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.4</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d776927dex104.htm">Form of Performance Share Continuous Vesting Grant Agreement </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.5</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d776927dex105.htm">Form of Executive Performance Unit Grant Agreement </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.6</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d776927dex106.htm">Form of Executive Performance Unit Continuous Vesting Grant Agreement </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.7</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d776927dex107.htm">Form of Restricted Stock Unit Annual Cliff Grant Agreement </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.8</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d776927dex108.htm">Form of Restricted Stock Unit Annual Ratable Grant Agreement </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.9</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d776927dex109.htm">Form of Restricted Stock Unit Continuous Vesting Grant Agreement </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:46%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:2%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:45%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-weight:bold">THE GOODYEAR TIRE&#160;&amp; RUBBER COMPANY</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: February 29, 2024</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">By</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Daniel T. Young</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Daniel T. Young</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Secretary</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d776927dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option Grant Agreement </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. These <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options for the number of shares of Common Stock indicated on the grant summary page (the
<FONT STYLE="white-space:nowrap">&#147;Non-Qualified</FONT> Stock Options&#148;) are granted to you under and are governed by the terms and conditions of the 2022 Performance Plan of The Goodyear Tire&nbsp;&amp; Rubber Company, adopted effective
April&nbsp;11, 2022 (as amended from time to time, the &#147;Plan&#148;), and this Grant Agreement. As your stock options are conveyed and managed online, your online acceptance constitutes your agreement to and acceptance of all terms and
conditions of the Plan and this Grant Agreement. You also agree that you have read and understand the Plan and this Grant Agreement. Capitalized terms used but not defined in this Grant Agreement have the meanings set forth in the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. You may exercise the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options granted pursuant to this Grant Agreement through (1)&nbsp;a cash
payment in the amount of the full option exercise price of the shares being purchased (including a simultaneous exercise and sale of the shares of Common Stock thereby acquired and use of the proceeds from such sale to pay the exercise price, to the
extent permitted by law) (a &#147;cash exercise&#148;), (2) a payment in full shares of Common Stock having a Fair Market Value on the date of exercise equal to the full option exercise price of the shares of Common Stock being purchased (a
&#147;share swap exercise&#148;), or (3)&nbsp;a combination of the cash exercise and share swap exercise methods. Any exercise of these <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options shall be by written notice stating the number
of shares of Common Stock to be purchased and the exercise method, accompanied with the payment, and proper proof of ownership if the share swap exercise method is used. You shall be required to meet the tax withholding obligations arising from any
exercise of <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. As further consideration for the
<FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options granted to you hereunder, you must remain in the continuous employ of the Company or one or more of its Subsidiaries from the Date of Grant to the date or dates the <FONT
STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options become exercisable as set forth on the grant summary page of this Grant Agreement before you will be entitled to exercise the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock
Options granted. The <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options you have been granted shall not in any event be exercisable after your termination of employment except as provided in paragraph 4 below for
&#147;Retirement&#148; (defined as termination of employment at any age after 30 or more years, or at age 55 or older with at least 10 years, of continuous service with the Company and its Subsidiaries), death, &#147;Disability&#148; (defined as
termination of employment while receiving benefits for a period of not less than one year under a long-term disability income plan provided by a government or sponsored by the Company or one of its Subsidiaries), or termination of your employment by
the Company and its Subsidiaries other than for Cause (as defined below). Notwithstanding the foregoing, in the event of a Change in Control while this grant is outstanding, the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options
shall be subject to the applicable provisions of Section&nbsp;14 of the Plan. For the avoidance of doubt, the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options you have been granted shall not be exercisable after termination of
employment as a result of your voluntary resignation (other than your Retirement), except as otherwise may be provided pursuant to Section&nbsp;14 of the Plan in the event of a Change in Control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. Except as otherwise may be provided pursuant to Section&nbsp;14 of the Plan in the event of a Change in Control, the
<FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options terminate automatically and shall not be exercisable by you from and after the date on which you cease to be an employee of the Company or one of its Subsidiaries for any reason
other than your death, Retirement, Disability, or termination of your employment by the Company and its Subsidiaries other than for Cause. In the event of your death, Retirement or Disability while an employee of the Company or one of its
Subsidiaries (and having been an employee continuously since the Date of Grant) on any date which is more than six (6)&nbsp;months after the Date of Grant of the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options specified on the
grant summary page of this Grant Agreement, the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options shall become immediately exercisable and, except as provided below in the event of your death while an employee, shall be exercisable
by you for the lesser of (a)&nbsp;the remainder of the term of the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option grant or (b)&nbsp;five years. In the event of your death while an employee, the
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option Grant Agreement </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options may be exercised for the lesser of (x)&nbsp;the remainder of the term of the
<FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option grant or (y)&nbsp;three years after your date of death by the person or persons to whom your rights in the options passed by your will or according to the laws of descent and
distribution. In the event of termination of your employment by the Company and its Subsidiaries other than for death, Disability or Cause, any vested <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options shall remain exercisable by
you for 90 days following the date of termination of your employment. For purposes of this Grant Agreement, &#147;Cause&#148; means (i)&nbsp;the continued failure by you to substantially perform your duties with the Company or its affiliates (other
than any such failure resulting from your incapacity due to physical or mental illness), (ii) your engaging in conduct which is demonstrably injurious to the Company or its affiliates, monetarily or otherwise, (iii)&nbsp;your committing any felony
or any crime involving fraud, breach of trust or misappropriation, or (iv)&nbsp;any breach or violation of any agreement relating to your employment with the Company or its affiliates where the Committee, in its sole but reasonable discretion,
determines that such breach or violation materially and adversely affects the Company or any affiliate. Nothing contained herein shall restrict the right of the Company or any of its Subsidiaries or affiliates to terminate your employment at any
time, with or without Cause. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. The <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options shall not in any event be exercisable after the
expiration of ten years from the Date of Grant specified on the grant summary page of this Grant Agreement and, to the extent not exercised, shall automatically terminate at the end of such <FONT STYLE="white-space:nowrap">ten-year</FONT> period.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. Certificates, or other evidence of beneficial ownership, for the shares of Common Stock purchased will be deliverable to you or your agent, duly
accredited to the satisfaction of the Company, at the principal office of the Company in Akron, Ohio, or at such other place acceptable to the Company as may be designated by you. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7. In the event your employment with the Company and its Subsidiaries is terminated for any reason whatsoever (whether voluntarily or involuntarily) and
within 18 months after such termination date you accept employment with a competitor of, or otherwise engage in competition with, the Company, the Committee, in its sole discretion, may require you to return, or (if not received) to forfeit, to the
Company the economic value of the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options granted hereunder which you have realized or obtained by your exercise at any time on or after the date which is six months prior to the date of
termination of your employment with the Company. Additionally, all <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options granted to you hereunder which you have not exercised shall be automatically cancelled upon commencement of your
competitive engagement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. Each <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option granted is not transferable by you otherwise than by
will or the laws of descent and distribution, and is exercisable during your lifetime only by you. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9. All rights conferred upon you under the provisions
of this Grant Agreement are personal and, except under the provisions of paragraph 8 of this Grant Agreement, no assignee, transferee or other successor in interest shall acquire any rights or interests whatsoever under this Grant Agreement, which
is made exclusively for the benefit of you and the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10. Any notice to you under this Grant Agreement shall be sufficient if in writing and if
delivered to you or mailed to you at the address on record in the Executive Compensation Department. Any notice to the Company under this Grant Agreement shall be sufficient if in writing and if delivered to the Executive Compensation Department of
the Company in Akron, Ohio, or mailed by registered mail directed to the Company for the attention of the Executive Compensation Department at 200 Innovation Way, Akron, Ohio 44316-0001. Either you or the Company may, by written notice, change the
address. This Grant Agreement shall be construed and shall take effect in accordance with the laws of the State of Ohio. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option Grant Agreement </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11. Each <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option may be exercised only at the
times and to the extent, and is subject to all of the terms and conditions, set forth in this Grant Agreement, and in the Plan, including any rule or regulation adopted by the Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12. In order to administer the Plan, the Company may process personal data about you. Such data includes, but is not limited to, the information provided in
this Grant Agreement and any changes thereto, other appropriate personal and financial data about you such as home and business addresses and other contact information, and any other information that might be deemed appropriate by the Company to
facilitate the administration of the Plan. By accepting this Grant Agreement, you give explicit consent to the Company to process any such personal data. You also give explicit consent to the Company to transfer any such personal data outside the
country in which you work or are employed, including, if you are not a U.S. resident, to the United States, to transferees that shall include the Company and other persons who are designated by the Company to administer the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">13. By accepting this Grant Agreement, you acknowledge that a copy of the Plan, the Prospectus, and the Company&#146;s most recent Annual Report and Proxy
Statement (the &#147;Prospectus Information&#148;) either have been received by or provided to you, and you consent to receiving the Prospectus Information electronically, or, in the alternative, agree to contact the Executive Compensation
Department of the Company to request a paper copy of the Prospectus Information at no charge. You also represent that you are familiar with the terms and provisions of the Prospectus Information and hereby accept this Grant Agreement on the terms
and subject to the conditions set forth herein and in the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">14. By accepting this Grant Agreement, you also agree and acknowledge that this Grant
Agreement and the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options are subject to the terms and conditions of The Goodyear Tire&nbsp;&amp; Rubber Company Compensation Recovery Policy as amended, supplemented or replaced from time
to time (the &#147;Policy&#148;). In the event it is determined by the Company that any amounts awarded, earned or paid under this Grant Agreement must be forfeited or reimbursed to the Company under the Policy, you will promptly take any action
necessary to effectuate such forfeiture or reimbursement as required by the Policy. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>d776927dex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option with tandem Stock Appreciation Right Grant Agreement </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. These <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options for the number of shares of Common Stock indicated on the grant summary page (the
<FONT STYLE="white-space:nowrap">&#147;Non-Qualified</FONT> Stock Options&#148;) and the Stock Appreciation Rights granted in tandem with the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options (the &#147;SARs&#148;) are granted to
you under and are governed by the terms and conditions of the 2022 Performance Plan of The Goodyear Tire&nbsp;&amp; Rubber Company, adopted effective April&nbsp;11, 2022 (as amended from time to time, the &#147;Plan&#148;), and this Grant Agreement.
As your stock options are conveyed and managed online, your online acceptance constitutes your agreement to and acceptance of all terms and conditions of the Plan and this Grant Agreement, including a recognition of the Company&#146;s right to
specify whether or not you may exercise either the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options or the SARs at the time you notify the Company of your intent to exercise. In the event that you are, or become subject to
taxation under the laws of the United States of America at any time prior to the expiration date, the grant hereunder shall be deemed to be a <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option and not a SAR for so long as you remain
subject to such tax laws. You also agree that you have read and understand the Plan and this Grant Agreement. Capitalized terms used but not defined in this Grant Agreement have the meanings set forth in the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. If the Company approves the exercise of a <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option, you may exercise the <FONT
STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options granted pursuant to this Grant Agreement through (1)&nbsp;a cash payment in the amount of the full option exercise price of the shares being purchased (including a simultaneous exercise
and sale of the shares of Common Stock thereby acquired and use of the proceeds from such sale to pay the exercise price, to the extent permitted by law) (a &#147;cash exercise&#148;), (2)&nbsp;a payment in full shares of Common Stock having a Fair
Market Value on the date of exercise equal to the full option exercise price of the shares of Common Stock being purchased (a &#147;share swap exercise&#148;), or (3)&nbsp;a combination of the cash exercise and share swap exercise methods. Any
exercise of these <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options shall be by written notice stating the number of shares of Common Stock to be purchased and the exercise method, accompanied with the payment, and proper proof of
ownership if the share swap exercise method is used. You shall be required to meet the tax withholding obligations arising from any exercise of <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. If the Company approves the exercise of the SARs, written notice must be given to the Company stating the number of shares of Common Stock in respect of
which the SARs are being exercised. In due course, you will receive payment in cash in an amount equal to the excess, if any, of the Fair Market Value of one share of Common Stock on the date of exercise of the SARs over the Option Exercise Price
per Share specified in respect of the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options multiplied by the number of shares of Common Stock in respect of which the SARs shall have been exercised. Such payment shall be subject to
reduction for withholding taxes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. As further consideration for the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options and SARs granted
to you hereunder, you must remain in the continuous employ of the Company or one or more of its Subsidiaries from the Date of Grant to the date or dates the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options and SARs become
exercisable as set forth on the grant summary page of this Grant Agreement before you will be entitled to exercise the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options and SARs granted. The
<FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options and SARs you have been granted shall not in any event be exercisable after your termination of employment except as provided in paragraph 5 below for &#147;Retirement&#148; (defined
as termination of employment at any age after 30 or more years, or at age 55 or older with at least 10 years, of continuous service with the Company and its Subsidiaries), death, &#147;Disability&#148; (defined as termination of employment while
receiving benefits for a period of not less than one year under a long-term disability income plan provided by a government or sponsored by the Company or one of its Subsidiaries), or termination of your employment by the Company and its
Subsidiaries other than for Cause (as defined below). Notwithstanding the foregoing, in the event of a Change in Control while this grant is outstanding, the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options and SARs shall be
subject to the applicable provisions of Section&nbsp;14 of the Plan. For the avoidance of doubt, the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options and SARs you have been granted shall not be exercisable after termination of
employment as a result of your voluntary resignation (other than your Retirement), except as otherwise may be provided pursuant to Section&nbsp;14 of the Plan in the event of a Change in Control. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option with tandem Stock Appreciation Right
Grant Agreement </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. Except as otherwise may be provided pursuant to Section&nbsp;14 of the Plan in the event of a Change in
Control, the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options and SARs terminate automatically and shall not be exercisable by you from and after the date on which you cease to be an employee of the Company or one of its
Subsidiaries for any reason other than your death, Retirement, Disability, or termination of your employment by the Company and its Subsidiaries other than for Cause. In the event of your death, Retirement or Disability while an employee of the
Company or one of its Subsidiaries (and having been an employee continuously since the Date of Grant) on any date which is more than six (6)&nbsp;months after the Date of Grant specified on the grant summary page of this Grant Agreement, the <FONT
STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options and SARs shall become immediately exercisable and, except as provided below in the event of your death while an employee, shall be exercisable by you for the lesser of (a)&nbsp;the
remainder of the term of the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option/SAR grant or (b)&nbsp;five years. In the event of your death while an employee, the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options
and SARs may be exercised for the lesser of (x)&nbsp;the remainder of the term of the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option/SAR grant or (y)&nbsp;three years after your date of death by the person or persons to whom your
rights in the options passed by your will or according to the laws of descent and distribution. In the event of termination of your employment by the Company and its Subsidiaries other than for death, Disability or Cause, any vested <FONT
STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options and SARs shall remain exercisable by you for 90 days following the date of termination of your employment. For purposes of this Grant Agreement, &#147;Cause&#148; means (i)&nbsp;the
continued failure by you to substantially perform your duties with the Company or its affiliates (other than any such failure resulting from your incapacity due to physical or mental illness), (ii)&nbsp;your engaging in conduct which is demonstrably
injurious to the Company or its affiliates, monetarily or otherwise, (iii)&nbsp;your committing any felony or any crime involving fraud, breach of trust or misappropriation, or (iv)&nbsp;any breach or violation of any agreement relating to your
employment with the Company or its affiliates where the Committee, in its sole but reasonable discretion, determines that such breach or violation materially and adversely affects the Company or any affiliate. Nothing contained herein shall restrict
the right of the Company or any of its Subsidiaries or affiliates to terminate your employment at any time, with or without Cause. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. The <FONT
STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options and SARs shall not in any event be exercisable after the expiration of ten years from the Date of Grant specified on the grant summary page of this Grant Agreement and, to the extent not
exercised, shall automatically terminate at the end of such <FONT STYLE="white-space:nowrap">ten-year</FONT> period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7. Certificates, or other evidence
of beneficial ownership, for the shares of Common Stock purchased pursuant to <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options will be deliverable to you or your agent, duly accredited to the satisfaction of the Company, at the
principal office of the Company in Akron, Ohio, or at such other place acceptable to the Company as may be designated by you. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. In the event your
employment with the Company and its Subsidiaries is terminated for any reason whatsoever (whether voluntarily or involuntarily) and within 18 months after such termination date you accept employment with a competitor of, or otherwise engage in
competition with, the Company, the Committee, in its sole discretion, may require you to return, or (if not received) to forfeit, to the Company the economic value of the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options or SARs
which you have realized or obtained by your exercise of the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options or SARs granted hereunder at any time on or after the date which is six months prior to the date of termination of your
employment with the Company. Additionally, all <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options or SARs granted to you hereunder which you have not exercised shall be automatically cancelled upon commencement of your competitive
engagement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9. Each <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option and SAR granted are not transferable by you otherwise than by will
or the laws of descent and distribution, and are exercisable during your lifetime only by you. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option with tandem Stock Appreciation Right
Grant Agreement </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10. All rights conferred upon you under the provisions of this Grant Agreement are personal and, except under
the provisions of paragraph 9 of this Grant Agreement, no assignee, transferee or other successor in interest shall acquire any rights or interests whatsoever under this Grant Agreement, which is made exclusively for the benefit of you and the
Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11. Any notice to you under this Grant Agreement shall be sufficient if in writing and if delivered to you or mailed to you at the address on
record in the Executive Compensation Department. Any notice to the Company under this Grant Agreement shall be sufficient if in writing and if delivered to the Executive Compensation Department of the Company in Akron, Ohio, or mailed by registered
mail directed to the Company for the attention of the Executive Compensation Department at 200 Innovation Way, Akron, Ohio 44316-0001. Either you or the Company may, by written notice, change the address. This Grant Agreement shall be construed and
shall take effect in accordance with the laws of the State of Ohio. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12. Each <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option and/or
SAR may be exercised only at the times and to the extent, and is subject to all of the terms and conditions, set forth in this Grant Agreement, and in the Plan, including any rule or regulation adopted by the Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">13. Your purchase of shares of Common Stock pursuant to the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options shall automatically reduce by
a like number the shares of Common Stock subject to the SARs and, conversely, your exercise of any SARs shall automatically reduce by a like number the shares of Common Stock available for purchase by you under the
<FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">14. In agreeing to accept this grant, you clearly acknowledge that The Goodyear
Tire&nbsp;&amp; Rubber Company assumes no responsibility for any regulatory or tax consequences that arise from either the grant or exercise of the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options or the SARs, whether under U.S.
or foreign law, rules, regulations or treaties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">15. Prior to the exercise of a <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option or SAR,
written notice must be given to the Company of your intent to exercise. The Company will then advise you whether or not you may exercise a <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option or SAR and upon receiving such advice you
may then exercise the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option or the SAR. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">16. In order to administer the Plan, the Company may
process personal data about you. Such data includes, but is not limited to, the information provided in this Grant Agreement and any changes thereto, other appropriate personal and financial data about you such as home and business addresses and
other contact information, and any other information that might be deemed appropriate by the Company to facilitate the administration of the Plan. By accepting this Grant Agreement, you give explicit consent to the Company to process any such
personal data. You also give explicit consent to the Company to transfer any such personal data outside the country in which you work or are employed, including, if you are not a U.S. resident, to the United States, to transferees that shall include
the Company and other persons who are designated by the Company to administer the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">17. By accepting this Grant Agreement, you acknowledge that a
copy of the Plan, the Prospectus, and the Company&#146;s most recent Annual Report and Proxy Statement (the &#147;Prospectus Information&#148;) either have been received by or provided to you, and you consent to receiving the Prospectus Information
electronically, or, in the alternative, agree to contact the Executive Compensation Department of the Company to request a paper copy of the Prospectus Information at no charge. You also represent that you are familiar with the terms and provisions
of the Prospectus Information and hereby accept this Grant Agreement on the terms and subject to the conditions set forth herein and in the Plan. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option with tandem Stock Appreciation Right
Grant Agreement </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">18. By accepting this Grant Agreement, you also agree and acknowledge that this Grant Agreement and the <FONT
STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options and the SARs are subject to the terms and conditions of The Goodyear Tire&nbsp;&amp; Rubber Company Compensation Recovery Policy as amended, supplemented or replaced from time to time
(the &#147;Policy&#148;). In the event it is determined by the Company that any amounts awarded, earned or paid under this Grant Agreement must be forfeited or reimbursed to the Company under the Policy, you will promptly take any action necessary
to effectuate such forfeiture or reimbursement as required by the Policy. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>d776927dex103.htm
<DESCRIPTION>EX-10.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.3 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Performance Share Annual Grant Agreement </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. This Performance
Share Grant is granted to you under, and governed by the terms and conditions of, the 2022 Performance Plan of The Goodyear Tire&nbsp;&amp; Rubber Company, adopted effective April&nbsp;11, 2022 (as amended from time to time, the &#147;Plan&#148;),
and this Grant Agreement. As your grant is conveyed and managed online, your online acceptance constitutes your agreement to and acceptance of all terms and conditions of the Plan and this Grant Agreement. You also agree that you have read and
understand the provisions of the Plan, this Grant Agreement and Annex A: 20__ &#150; 20__ LTI Targets and Ranges, referred to as &#147;Annex A&#148;. Capitalized terms used but not defined in this Grant Agreement have the meanings set forth in the
Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. All rights conferred upon you under the provisions of this Grant Agreement are personal to you and no assignee, transferee or other successor in
interest shall acquire any rights or interests whatsoever under this Grant Agreement, which is made exclusively for the benefit of you and the Company, except by will or the laws of descent and distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. Except as otherwise provided in this Section&nbsp;3 or as may be provided pursuant to Section&nbsp;14 of the Plan in the event of a Change in Control, the
number of Units earned will be determined and contingent upon the extent to which Performance Goals are achieved during a Performance Period, as described in Annex A and as determined by the Committee. As further consideration for the Units granted
to you hereunder, except as otherwise provided in this Section&nbsp;3, you must remain in the continuous employ of the Company or one or more of its Subsidiaries until <B>December</B><B></B><B>&nbsp;31, 20__</B> (the &#147;Vesting Date&#148;). </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event of your &#147;Retirement&#148; (defined as termination of employment at any age after 30 or more
years, or at age 55 or older with at least 10 years, of continuous service with the Company and its Subsidiaries) on any date which is more than six (6)&nbsp;months after the Date of Grant and prior to completion of a Performance Period, you will
receive a prorated number of Units based on the date of your termination of employment with the Company and actual achievement of the Performance Goals as determined by the Committee following the end of the Performance Period. In the event of your
Retirement on or prior to the Vesting Date but after completion of a Performance Period, you will receive the number of Units earned as determined by the Committee following the end of the Performance Period. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event of your death or &#147;Disability&#148; (defined as termination of employment while receiving
benefits for a period of not less than one year under a long-term disability income plan provided by a government or sponsored by the Company or one of its Subsidiaries) on any date which is more than six (6)&nbsp;months after the Date of Grant and
prior to completion of a Performance Period, you or your legal representative will receive a prorated number of Units based on the date of your termination of employment with the Company and target achievement of the Performance Goals for that
Performance Period. In the event of your death or Disability on or prior to the Vesting Date but after completion of a Performance Period, you or your legal representative will receive the number of Units earned as determined by the Committee
following the end of the Performance Period. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notwithstanding Section&nbsp;14(a)(2) of the Plan, in the event that you incur a Severance before or during a
Performance Period, the Units with respect to any such Performance Period shall be deemed to have been fully earned at the target amount of the award opportunity, and in the event that you incur a Severance on or prior to the Vesting Date but after
completion of a Performance Period, the Units with respect to any such completed Performance Period shall be deemed to have been fully earned in the amount determined by the Committee following the end of the Performance Period.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">d.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Nothing contained herein shall restrict the right of the Company or any of its Subsidiaries or affiliates to
terminate your employment at any time, with or without cause. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Performance Share Annual Grant Agreement </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. In the event your employment with the Company and its Subsidiaries is terminated for any reason whatsoever
(whether voluntarily or involuntarily) and within 18 months after such termination date you accept employment with a competitor of, or otherwise engage in competition with, the Company, the Committee, in its sole discretion, may require you to
return, or (if not received) to forfeit, to the Company the payments made (or to be made) hereunder which you have received (or will receive) at any time on or after the date which is six months prior to the date of termination of your employment
with the Company. Additionally, all Units granted to you hereunder which are outstanding shall be automatically cancelled upon commencement of your competitive engagement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. The Company will pay to you 100% of the total number of whole Units earned in shares of Common Stock (with each Unit being equivalent to one share of
Common Stock), less such withholding and payroll taxes as the Company shall determine to be necessary or appropriate (with cash paid with respect to any fractional share of Common Stock). Any payment pursuant to Section&nbsp;5 of this Grant
Agreement shall be made (i)&nbsp;after the Vesting Date but in no event later than <B>March</B><B></B><B>&nbsp;15, 20__ </B>(including any payments following your Retirement), (ii) in the event of your death or Disability, within the later of (a) 60
days after your termination of employment or (b)&nbsp;March&nbsp;15 of the year of your termination of employment, or (iii)&nbsp;in the event of your earlier Severance, within 30 days after your Severance. No Dividend Equivalents will be paid or
provided pursuant to this Grant Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. You will be required to satisfy all Federal, state and local tax and payroll withholding obligations, and
any other withholding obligations, arising in respect of any distribution of, or right to receive any distribution of, shares of Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7. Any
notice to you under this Grant Agreement shall be sufficient if in writing and if delivered to you or mailed to you at the address on record in the Executive Compensation Department. Any notice to the Company under this Grant Agreement shall be
sufficient if in writing and if delivered to the Executive Compensation Department of the Company in Akron, Ohio, or mailed by registered mail directed to the Company for the attention of the Executive Compensation Department at 200 Innovation Way,
Akron, Ohio 44316-0001. Either you or the Company may, by written notice, change the address. This Grant Agreement shall be construed and shall take effect in accordance with the laws of the State of Ohio. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. The obligations of the Company under this Grant Agreement will be merely that of an unfunded and unsecured promise of the Company to deliver shares of
Common Stock in the future, and your rights will be no greater than that of an unsecured general creditor. No assets of the Company will be held or set aside as security for the obligations of the Company under this Grant Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9. It is intended that this Grant Agreement shall either be exempt from the application of, or comply with, the requirements of Section&nbsp;409A of the Code.
This Grant Agreement shall be construed, administered and governed in a manner that effects such intent, and the Committee shall not take any action that would be inconsistent with such intent. Without limiting the foregoing, the Units shall not be
deferred, accelerated, extended, paid out, settled, adjusted, substituted, exchanged or modified in a manner that would cause the award to fail to satisfy the conditions of an applicable exception from the requirements of Section&nbsp;409A of the
Code or otherwise would subject you to the additional tax imposed under Section&nbsp;409A of the Code. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Performance Share Annual Grant Agreement </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding anything contained in this Grant Agreement to the contrary, if you are a &#147;specified
employee,&#148; within the meaning of Section&nbsp;409A of the Code, with December&nbsp;31 being the specified employee identification date and the following January&nbsp;1 being the specified employee effective date, on the date you incur a
separation from service, then to the extent required in order to comply with Section&nbsp;409A of the Code, all payments under this Grant Agreement that constitute a &#147;deferral of compensation&#148; within the meaning of Section&nbsp;409A of the
Code, that are provided as a result of a separation from service and that would otherwise be paid during the first six months following such separation from service shall be accumulated through and paid on the first business day that is more than
six months following your separation from service (or, if you die during such <FONT STYLE="white-space:nowrap">six-month</FONT> period, within 90 days after your death). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10. In order to administer the Plan, the Company may process personal data about you. Such data includes, but is not limited to, the information provided in
this Grant Agreement and any changes thereto, other appropriate personal and financial data about you such as home and business addresses and other contact information, and any other information that might be deemed appropriate by the Company to
facilitate the administration of the Plan. By accepting this Grant Agreement, you give explicit consent to the Company to process any such personal data. You also give explicit consent to the Company to transfer any such personal data outside the
country in which you work or are employed, including, if you are not a U.S. resident, to the United States, to transferees that shall include the Company and other persons who are designated by the Company to administer the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11. By accepting this Grant Agreement, you acknowledge that a copy of the Plan, the Prospectus, and the Company&#146;s most recent Annual Report and Proxy
Statement (the &#147;Prospectus Information&#148;) either have been received by or provided to you, and you consent to receiving the Prospectus Information electronically, or, in the alternative, agree to contact the Executive Compensation
Department of the Company to request a paper copy of the Prospectus Information at no charge. You also represent that you are familiar with the terms and provisions of the Prospectus Information and hereby accept this Grant Agreement on the terms
and subject to the conditions set forth herein and in the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12. By accepting this Grant Agreement, you also agree and acknowledge that this Grant
Agreement and the Units are subject to the terms and conditions of The Goodyear Tire&nbsp;&amp; Rubber Company Compensation Recovery Policy as amended, supplemented or replaced from time to time (the &#147;Policy&#148;). In the event it is
determined by the Company that any amounts awarded, earned or paid under this Grant Agreement must be forfeited or reimbursed to the Company under the Policy, you will promptly take any action necessary to effectuate such forfeiture or reimbursement
as required by the Policy. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>d776927dex104.htm
<DESCRIPTION>EX-10.4
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.4</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.4 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Performance Share Continuous Vesting Grant Agreement </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. This
Performance Share Grant is granted to you under, and governed by the terms and conditions of, the 2022 Performance Plan of The Goodyear Tire&nbsp;&amp; Rubber Company, adopted effective April&nbsp;11, 2022 (as amended from time to time, the
&#147;Plan&#148;), and this Grant Agreement. As your grant is conveyed and managed online, your online acceptance constitutes your agreement to and acceptance of all terms and conditions of the Plan and this Grant Agreement. You also agree that you
have read and understand the provisions of the Plan, this Grant Agreement and Annex A: 20__ &#150; 20__ LTI Targets and Ranges, referred to as &#147;Annex A&#148;. Capitalized terms used but not defined in this Grant Agreement have the meanings set
forth in the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. All rights conferred upon you under the provisions of this Grant Agreement are personal to you and no assignee, transferee or other
successor in interest shall acquire any rights or interests whatsoever under this Grant Agreement, which is made exclusively for the benefit of you and the Company, except by will or the laws of descent and distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. Except as otherwise provided in this Section&nbsp;3 or as may be provided pursuant to Section&nbsp;14 of the Plan in the event of a Change in Control, the
number of Units earned will be determined and contingent upon the extent to which Performance Goals are achieved during a Performance Period, as described in Annex A and as determined by the Committee. As further consideration for the Units granted
to you hereunder, except as otherwise provided in this Section&nbsp;3, you must remain in the continuous employ of the Company or one or more of its Subsidiaries until <B>December</B><B></B><B>&nbsp;31, 20__</B> (the &#147;Vesting Date&#148;). </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event of your &#147;Retirement&#148; (defined as termination of employment at any age after 30 or more
years, or at age 55 or older with at least 10 years, of continuous service with the Company and its Subsidiaries) on any date which is more than six (6)&nbsp;months after the Date of Grant and prior to completion of a Performance Period, you will
receive a prorated number of Units based on the date of your termination of employment with the Company and actual achievement of the Performance Goals as determined by the Committee following the end of the Performance Period; provided, however,
that if you remain in the continuous employ of the Company or one or more of its Subsidiaries until at least <B>December</B><B></B><B>&nbsp;31, 20__</B>, the Units granted to you hereunder will be deemed to be fully vested and you will receive the
number of Units actually earned as determined by the Committee following the end of the Performance Period, which will be payable as provided in Section&nbsp;5. In the event of your Retirement on or prior to the Vesting Date but after completion of
a Performance Period, you will receive the number of Units earned as determined by the Committee following the end of the Performance Period. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event of your death or &#147;Disability&#148; (defined as termination of employment while receiving
benefits for a period of not less than one year under a long-term disability income plan provided by a government or sponsored by the Company or one of its Subsidiaries) on any date which is more than six (6)&nbsp;months after the Date of Grant and
prior to completion of a Performance Period, you or your legal representative will receive a prorated number of Units based on the date of your termination of employment with the Company and target achievement of the Performance Goals for that
Performance Period; provided, however, that if you remain in the continuous employ of the Company or one or more of its Subsidiaries until at least <B>December</B><B></B><B>&nbsp;31, 20__</B>, the Units granted to you hereunder will be deemed to be
fully vested and you or your legal representative will receive a number of Units based on target achievement of the Performance Goals for that Performance Period, which will be payable as provided in Section&nbsp;7. In the event of your death or
Disability on or prior to the Vesting Date but after completion of a Performance Period, you or your legal representative will receive the number of Units earned as determined by the Committee following the end of the Performance Period.
</P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Performance Share Continuous Vesting Grant Agreement </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notwithstanding Section&nbsp;14(a)(2) of the Plan, in the event that you incur a Severance before or during a
Performance Period, the Units with respect to any such Performance Period shall be deemed to have been fully earned at the target amount of the award opportunity, and in the event that you incur a Severance on or prior to the Vesting Date but after
completion of a Performance Period, the Units with respect to any such completed Performance Period shall be deemed to have been fully earned in the amount determined by the Committee following the end of the Performance Period.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">d.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Nothing contained herein shall restrict the right of the Company or any of its Subsidiaries or affiliates to
terminate your employment at any time, with or without cause. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. In the event your employment with the Company and its Subsidiaries is
terminated for any reason whatsoever (whether voluntarily or involuntarily) and within 18 months after such termination date you accept employment with a competitor of, or otherwise engage in competition with, the Company, the Committee, in its sole
discretion, may require you to return, or (if not received) to forfeit, to the Company the payments made (or to be made) hereunder which you have received (or will receive) at any time on or after the date which is six months prior to the date of
termination of your employment with the Company. Additionally, all Units granted to you hereunder which are outstanding shall be automatically cancelled upon commencement of your competitive engagement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. The Company will pay to you 100% of the total number of whole Units earned in shares of Common Stock (with each Unit being equivalent to one share of
Common Stock), less such withholding and payroll taxes as the Company shall determine to be necessary or appropriate (with cash paid with respect to any fractional share of Common Stock). Any payment pursuant to Section&nbsp;5 of this Grant
Agreement shall be made (i)&nbsp;after the Vesting Date but in no event later than <B>March</B><B></B><B>&nbsp;15, 20__ </B>(including any payments following your Retirement), (ii) in the event of your death or Disability, within the later of (a) 60
days after your termination of employment or (b)&nbsp;March&nbsp;15 of the year of your termination of employment, or (iii)&nbsp;in the event of your earlier Severance, within 30 days after your Severance. No Dividend Equivalents will be paid or
provided pursuant to this Grant Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. You will be required to satisfy all Federal, state and local tax and payroll withholding obligations, and
any other withholding obligations, arising in respect of any distribution of, or right to receive any distribution of, shares of Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7. Any
notice to you under this Grant Agreement shall be sufficient if in writing and if delivered to you or mailed to you at the address on record in the Executive Compensation Department. Any notice to the Company under this Grant Agreement shall be
sufficient if in writing and if delivered to the Executive Compensation Department of the Company in Akron, Ohio, or mailed by registered mail directed to the Company for the attention of the Executive Compensation Department at 200 Innovation Way,
Akron, Ohio 44316-0001. Either you or the Company may, by written notice, change the address. This Grant Agreement shall be construed and shall take effect in accordance with the laws of the State of Ohio. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. The obligations of the Company under this Grant Agreement will be merely that of an unfunded and unsecured promise of the Company to deliver shares of
Common Stock in the future, and your rights will be no greater than that of an unsecured general creditor. No assets of the Company will be held or set aside as security for the obligations of the Company under this Grant Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9. It is intended that this Grant Agreement shall either be exempt from the application of, or comply with, the requirements of Section&nbsp;409A of the Code.
This Grant Agreement shall be construed, administered and governed in a manner that effects such intent, and the Committee shall not take any action that would be inconsistent with such intent. Without limiting the foregoing, the Units shall not be
deferred, accelerated, extended, paid out, settled, adjusted, substituted, exchanged or modified in a manner that would cause the award to fail to satisfy the conditions of an applicable exception from the requirements of Section&nbsp;409A of the
Code or otherwise would subject you to the additional tax imposed under Section&nbsp;409A of the Code. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Performance Share Continuous Vesting Grant Agreement </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding anything contained in this Grant Agreement to the contrary, if you are a &#147;specified
employee,&#148; within the meaning of Section&nbsp;409A of the Code, with December&nbsp;31 being the specified employee identification date and the following January&nbsp;1 being the specified employee effective date, on the date you incur a
separation from service, then to the extent required in order to comply with Section&nbsp;409A of the Code, all payments under this Grant Agreement that constitute a &#147;deferral of compensation&#148; within the meaning of Section&nbsp;409A of the
Code, that are provided as a result of a separation from service and that would otherwise be paid during the first six months following such separation from service shall be accumulated through and paid on the first business day that is more than
six months following your separation from service (or, if you die during such <FONT STYLE="white-space:nowrap">six-month</FONT> period, within 90 days after your death). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10. In order to administer the Plan, the Company may process personal data about you. Such data includes, but is not limited to, the information provided in
this Grant Agreement and any changes thereto, other appropriate personal and financial data about you such as home and business addresses and other contact information, and any other information that might be deemed appropriate by the Company to
facilitate the administration of the Plan. By accepting this Grant Agreement, you give explicit consent to the Company to process any such personal data. You also give explicit consent to the Company to transfer any such personal data outside the
country in which you work or are employed, including, if you are not a U.S. resident, to the United States, to transferees that shall include the Company and other persons who are designated by the Company to administer the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11. By accepting this Grant Agreement, you acknowledge that a copy of the Plan, the Prospectus, and the Company&#146;s most recent Annual Report and Proxy
Statement (the &#147;Prospectus Information&#148;) either have been received by or provided to you, and you consent to receiving the Prospectus Information electronically, or, in the alternative, agree to contact the Executive Compensation
Department of the Company to request a paper copy of the Prospectus Information at no charge. You also represent that you are familiar with the terms and provisions of the Prospectus Information and hereby accept this Grant Agreement on the terms
and subject to the conditions set forth herein and in the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12. By accepting this Grant Agreement, you also agree and acknowledge that this Grant
Agreement and the Units are subject to the terms and conditions of The Goodyear Tire&nbsp;&amp; Rubber Company Compensation Recovery Policy as amended, supplemented or replaced from time to time (the &#147;Policy&#148;). In the event it is
determined by the Company that any amounts awarded, earned or paid under this Grant Agreement must be forfeited or reimbursed to the Company under the Policy, you will promptly take any action necessary to effectuate such forfeiture or reimbursement
as required by the Policy. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>6
<FILENAME>d776927dex105.htm
<DESCRIPTION>EX-10.5
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.5</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.5 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive Performance Unit Grant Agreement </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. This Executive
Performance Unit Grant is granted to you under, and governed by the terms and conditions of, the 2022 Performance Plan of The Goodyear Tire&nbsp;&amp; Rubber Company, adopted effective April&nbsp;11, 2022 (as amended from time to time, the
&#147;Plan&#148;), and this Grant Agreement. As your grant is conveyed and managed online, your online acceptance constitutes your agreement to and acceptance of all terms and conditions of the Plan and this Grant Agreement. You also agree that you
have read and understand the provisions of the Plan, this Grant Agreement and Annex A: ___ &#150; ____ LTI Targets and Ranges, referred to as &#147;Annex A&#148;. Capitalized terms used but not defined in this Grant Agreement have the meanings set
forth in the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. All rights conferred upon you under the provisions of this Grant Agreement are personal to you and no assignee, transferee or other
successor in interest shall acquire any rights or interests whatsoever under this Grant Agreement, which is made exclusively for the benefit of you and the Company, except by will or the laws of descent and distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. Except as otherwise provided in Section&nbsp;4 or as may be provided pursuant to Section&nbsp;14 of the Plan in the event of a Change in Control, the
number of Units earned (the &#147;Performance Award&#148;) will be determined and contingent upon the extent to which Performance Goals are achieved during a Performance Period, as described in Annex A and as determined by the Committee, and will be
paid as provided in Section&nbsp;7 of this Grant Agreement. All Performance Awards will be paid in cash. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. As further consideration for the Units
granted to you hereunder, except as otherwise provided in this Section&nbsp;4, you must remain in the continuous employ of the Company or one or more of its Subsidiaries until <B>December</B><B></B><B>&nbsp;31, 20__</B> (the &#147;Vesting
Date&#148;). </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event of your &#147;Retirement&#148; (defined as termination of employment at any age after 30 or more
years, or at age 55 or older with at least 10 years, of continuous service with the Company and its Subsidiaries) on any date which is more than six (6)&nbsp;months after the Date of Grant and prior to completion of a Performance Period, you will
receive a prorated number of Units based on the date of your termination of employment with the Company and actual achievement of the Performance Goals as determined by the Committee following the end of the Performance Period. In the event of your
Retirement on or prior to the Vesting Date but after completion of a Performance Period, you will receive the number of Units earned as determined by the Committee following the end of the Performance Period. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event of your death or &#147;Disability&#148; (defined as termination of employment while receiving
benefits for a period of not less than one year under a long-term disability income plan provided by a government or sponsored by the Company or one of its Subsidiaries) on any date which is more than six (6)&nbsp;months after the Date of Grant and
prior to completion of a Performance Period, you or your legal representative will receive a prorated number of Units based on the date of your termination of employment with the Company and target achievement of the Performance Goals for that
Performance Period. In the event of your death or Disability on or prior to the Vesting Date but after completion of a Performance Period, you or your legal representative will receive the number of Units earned as determined by the Committee
following the end of the Performance Period. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notwithstanding Section&nbsp;14(a)(2) of the Plan, in the event that you incur a Severance before or during a
Performance Period, the Units with respect to any such Performance Period shall be deemed to have been fully earned at the target amount of the award opportunity, and in the event that you incur a Severance on or prior to the Vesting Date but after
completion of a Performance Period, the Units with respect to any such completed Performance Period shall be deemed to have been fully earned in the amount determined by the Committee following the end of the Performance Period.
</P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive Performance Unit Grant Agreement </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">d.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Nothing contained herein shall restrict the right of the Company or any of its Subsidiaries or affiliates to
terminate your employment at any time, with or without cause. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. In the event your employment with the Company and its Subsidiaries is
terminated for any reason whatsoever (whether voluntarily or involuntarily) and within 18 months after such termination date you accept employment with a competitor of, or otherwise engage in competition with, the Company, the Committee, in its sole
discretion, may require you to return, or (if not received) to forfeit, to the Company the payments made (or to be made) hereunder which you have received (or will receive) at any time on or after the date which is six months prior to the date of
termination of your employment with the Company. Additionally, all Units granted to you hereunder which are outstanding shall be automatically cancelled upon commencement of your competitive engagement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. You will be required to satisfy all Federal, state and local tax and payroll withholding obligations, and any other withholding obligations, arising in
respect of any distribution of, or right to receive any distribution of, cash to you. Such withholding obligations will be deducted from your Units. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.
Except as otherwise provided in accordance with an election permitted under a deferred compensation plan approved by the Committee, any payment of a Performance Award shall be made (i)&nbsp;after the Vesting Date but in no event later than
<B>March</B><B></B><B>&nbsp;15, 20__ </B>(including any payments following your Retirement), (ii) in the event of your death or Disability, within the later of (a) 60 days after your termination of employment or (b)&nbsp;March&nbsp;15 of the year of
your termination of employment, or (iii)&nbsp;in the event of your earlier Severance, within 30 days after your Severance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. Any notice to you under
this Grant Agreement shall be sufficient if in writing and if delivered to you or mailed to you at the address on record in the Executive Compensation Department. Any notice to the Company under this Grant Agreement shall be sufficient if in writing
and if delivered to the Executive Compensation Department of the Company in Akron, Ohio, or mailed by registered mail directed to the Company for the attention of the Executive Compensation Department at 200 Innovation Way, Akron, Ohio 44316-0001.
Either you or the Company may, by written notice, change the address. This Grant Agreement shall be construed and shall take effect in accordance with the laws of the State of Ohio. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9. The obligations of the Company under this Grant Agreement will be merely that of an unfunded and unsecured promise of the Company to deliver cash in the
future, and your rights will be no greater than that of an unsecured general creditor. No assets of the Company will be held or set aside as security for the obligations of the Company under this Grant Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10. It is intended that this Grant Agreement shall either be exempt from the application of, or comply with, the requirements of Section&nbsp;409A of the
Code. This Grant Agreement shall be construed, administered and governed in a manner that effects such intent, and the Committee shall not take any action that would be inconsistent with such intent. Without limiting the foregoing, the Units shall
not be deferred, accelerated, extended, paid out, settled, adjusted, substituted, exchanged or modified in a manner that would cause the award to fail to satisfy the conditions of an applicable exception from the requirements of Section&nbsp;409A of
the Code or otherwise would subject you to the additional tax imposed under Section&nbsp;409A of the Code. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive Performance Unit Grant Agreement </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding anything contained in this Grant Agreement to the contrary, if you are a &#147;specified
employee,&#148; within the meaning of Section&nbsp;409A of the Code, with December&nbsp;31 being the specified employee identification date and the following January&nbsp;1 being the specified employee effective date, on the date you incur a
separation from service, then to the extent required in order to comply with Section&nbsp;409A of the Code, all payments under this Grant Agreement that constitute a &#147;deferral of compensation&#148; within the meaning of Section&nbsp;409A of the
Code, that are provided as a result of a separation from service and that would otherwise be paid during the first six months following such separation from service shall be accumulated through and paid (together with interest on any cash amounts at
the applicable federal rate under Section&nbsp;7872(f)(2)(A) of the Code in effect on the date of termination), on the first business day that is more than six months following your separation from service (or, if you die during such <FONT
STYLE="white-space:nowrap">six-month</FONT> period, within 90 days after your death). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11. In order to administer the Plan, the Company may process
personal data about you. Such data includes, but is not limited to, the information provided in this Grant Agreement and any changes thereto, other appropriate personal and financial data about you such as home and business addresses and other
contact information, and any other information that might be deemed appropriate by the Company to facilitate the administration of the Plan. By accepting this Grant Agreement, you give explicit consent to the Company to process any such personal
data. You also give explicit consent to the Company to transfer any such personal data outside the country in which you work or are employed, including, if you are not a U.S. resident, to the United States, to transferees that shall include the
Company and other persons who are designated by the Company to administer the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12. By accepting this Grant Agreement, you acknowledge that a copy of
the Plan, the Prospectus, and the Company&#146;s most recent Annual Report and Proxy Statement (the &#147;Prospectus Information&#148;) either have been received by or provided to you, and you consent to receiving the Prospectus Information
electronically, or, in the alternative, agree to contact the Executive Compensation Department of the Company to request a paper copy of the Prospectus Information at no charge. You also represent that you are familiar with the terms and provisions
of the Prospectus Information and hereby accept this Grant Agreement on the terms and subject to the conditions set forth herein and in the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">13. By
accepting this Grant Agreement, you also agree and acknowledge that this Grant Agreement and the Units are subject to the terms and conditions of The Goodyear Tire&nbsp;&amp; Rubber Company Compensation Recovery Policy as amended, supplemented or
replaced from time to time (the &#147;Policy&#148;). In the event it is determined by the Company that any amounts awarded, earned or paid under this Grant Agreement must be forfeited or reimbursed to the Company under the Policy, you will promptly
take any action necessary to effectuate such forfeiture or reimbursement as required by the Policy. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>7
<FILENAME>d776927dex106.htm
<DESCRIPTION>EX-10.6
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.6</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.6 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive Performance Unit Continuous Vesting Grant Agreement </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. This Executive Performance Unit Grant is granted to you under, and governed by the terms and conditions of, the 2022 Performance Plan of The Goodyear
Tire&nbsp;&amp; Rubber Company, adopted effective April&nbsp;11, 2022 (as amended from time to time, the &#147;Plan&#148;), and this Grant Agreement. As your grant is conveyed and managed online, your online acceptance constitutes your agreement to
and acceptance of all terms and conditions of the Plan and this Grant Agreement. You also agree that you have read and understand the provisions of the Plan, this Grant Agreement and Annex A: ___ &#150; ____ LTI Targets and Ranges, referred to as
&#147;Annex A&#148;. Capitalized terms used but not defined in this Grant Agreement have the meanings set forth in the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. All rights conferred upon
you under the provisions of this Grant Agreement are personal to you and no assignee, transferee or other successor in interest shall acquire any rights or interests whatsoever under this Grant Agreement, which is made exclusively for the benefit of
you and the Company, except by will or the laws of descent and distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. Except as otherwise provided in Section&nbsp;4 or as may be provided
pursuant to Section&nbsp;14 of the Plan in the event of a Change in Control, the number of Units earned (the &#147;Performance Award&#148;) will be determined and contingent upon the extent to which Performance Goals are achieved during a
Performance Period, as described in Annex A and as determined by the Committee, and will be paid as provided in Section&nbsp;7 of this Grant Agreement. All Performance Awards will be paid in cash. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. As further consideration for the Units granted to you hereunder, except as otherwise provided in this Section&nbsp;4, you must remain in the continuous
employ of the Company or one or more of its Subsidiaries until <B>December</B><B></B><B>&nbsp;31, 20__</B> (the &#147;Vesting Date&#148;). </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event of your &#147;Retirement&#148; (defined as termination of employment at any age after 30 or more
years, or at age 55 or older with at least 10 years, of continuous service with the Company and its Subsidiaries) on any date which is more than six (6)&nbsp;months after the Date of Grant and prior to completion of a Performance Period, you will
receive a prorated number of Units based on the date of your termination of employment with the Company and actual achievement of the Performance Goals as determined by the Committee following the end of the Performance Period; provided, however,
that if you remain in the continuous employ of the Company or one or more of its Subsidiaries until at least <B>December</B><B></B><B>&nbsp;31, 20__</B>, the Units granted to you hereunder will be deemed to be fully vested and you will receive the
number of Units actually earned as determined by the Committee following the end of the Performance Period, which will be payable as provided in Section&nbsp;7. In the event of your Retirement on or prior to the Vesting Date but after completion of
a Performance Period, you will receive the number of Units earned as determined by the Committee following the end of the Performance Period. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event of your death or &#147;Disability&#148; (defined as termination of employment while receiving
benefits for a period of not less than one year under a long-term disability income plan provided by a government or sponsored by the Company or one of its Subsidiaries) on any date which is more than six (6)&nbsp;months after the Date of Grant and
prior to completion of a Performance Period, you or your legal representative will receive a prorated number of Units based on the date of your termination of employment with the Company and target achievement of the Performance Goals for that
Performance Period; provided, however, that if you remain in the continuous employ of the Company or one or more of its Subsidiaries until at least <B>December</B><B></B><B>&nbsp;31, 20__</B>, the Units granted to you hereunder will be deemed to be
fully vested and you or your legal representative will receive a number of Units based on target achievement of the Performance Goals for that Performance Period, which will be payable as provided in Section&nbsp;7. In the event of your death or
Disability on or prior to the Vesting Date but after completion of a Performance Period, you or your legal representative will receive the number of Units earned as determined by the Committee following the end of the Performance Period.
</P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive Performance Unit Continuous Vesting Grant Agreement </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notwithstanding Section&nbsp;14(a)(2) of the Plan, in the event that you incur a Severance before or during a
Performance Period, the Units with respect to any such Performance Period shall be deemed to have been fully earned at the target amount of the award opportunity, and in the event that you incur a Severance on or prior to the Vesting Date but after
completion of a Performance Period, the Units with respect to any such completed Performance Period shall be deemed to have been fully earned in the amount determined by the Committee following the end of the Performance Period.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">d.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Nothing contained herein shall restrict the right of the Company or any of its Subsidiaries or affiliates to
terminate your employment at any time, with or without cause. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. In the event your employment with the Company and its Subsidiaries is
terminated for any reason whatsoever (whether voluntarily or involuntarily) and within 18 months after such termination date you accept employment with a competitor of, or otherwise engage in competition with, the Company, the Committee, in its sole
discretion, may require you to return, or (if not received) to forfeit, to the Company the payments made (or to be made) hereunder which you have received (or will receive) at any time on or after the date which is six months prior to the date of
termination of your employment with the Company. Additionally, all Units granted to you hereunder which are outstanding shall be automatically cancelled upon commencement of your competitive engagement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. You will be required to satisfy all Federal, state and local tax and payroll withholding obligations, and any other withholding obligations, arising in
respect of any distribution of, or right to receive any distribution of, cash to you. Such withholding obligations will be deducted from your Units. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.
Except as otherwise provided in accordance with an election permitted under a deferred compensation plan approved by the Committee, any payment of a Performance Award shall be made (i)&nbsp;after the Vesting Date but in no event later than
<B>March</B><B></B><B>&nbsp;15, 20__ </B>(including any payments following your Retirement), (ii) in the event of your death or Disability, within the later of (a) 60 days after your termination of employment or (b)&nbsp;March&nbsp;15 of the year of
your termination of employment, or (iii)&nbsp;in the event of your earlier Severance, within 30 days after your Severance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. Any notice to you under
this Grant Agreement shall be sufficient if in writing and if delivered to you or mailed to you at the address on record in the Executive Compensation Department. Any notice to the Company under this Grant Agreement shall be sufficient if in writing
and if delivered to the Executive Compensation Department of the Company in Akron, Ohio, or mailed by registered mail directed to the Company for the attention of the Executive Compensation Department at 200 Innovation Way, Akron, Ohio 44316-0001.
Either you or the Company may, by written notice, change the address. This Grant Agreement shall be construed and shall take effect in accordance with the laws of the State of Ohio. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9. The obligations of the Company under this Grant Agreement will be merely that of an unfunded and unsecured promise of the Company to deliver cash in the
future, and your rights will be no greater than that of an unsecured general creditor. No assets of the Company will be held or set aside as security for the obligations of the Company under this Grant Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10. It is intended that this Grant Agreement shall either be exempt from the application of, or comply with, the requirements of Section&nbsp;409A of the
Code. This Grant Agreement shall be construed, administered and governed in a manner that effects such intent, and the Committee shall not take any action that would be inconsistent with such intent. Without limiting the foregoing, the Units shall
not be deferred, accelerated, extended, paid out, settled, adjusted, substituted, exchanged or modified in a manner that would cause the award to fail to satisfy the conditions of an applicable exception from the requirements of Section&nbsp;409A of
the Code or otherwise would subject you to the additional tax imposed under Section&nbsp;409A of the Code. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive Performance Unit Continuous Vesting Grant Agreement </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding anything contained in this Grant Agreement to the contrary, if you are a &#147;specified
employee,&#148; within the meaning of Section&nbsp;409A of the Code, with December&nbsp;31 being the specified employee identification date and the following January&nbsp;1 being the specified employee effective date, on the date you incur a
separation from service, then to the extent required in order to comply with Section&nbsp;409A of the Code, all payments under this Grant Agreement that constitute a &#147;deferral of compensation&#148; within the meaning of Section&nbsp;409A of the
Code, that are provided as a result of a separation from service and that would otherwise be paid during the first six months following such separation from service shall be accumulated through and paid (together with interest on any cash amounts at
the applicable federal rate under Section&nbsp;7872(f)(2)(A) of the Code in effect on the date of termination), on the first business day that is more than six months following your separation from service (or, if you die during such <FONT
STYLE="white-space:nowrap">six-month</FONT> period, within 90 days after your death). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11. In order to administer the Plan, the Company may process
personal data about you. Such data includes, but is not limited to, the information provided in this Grant Agreement and any changes thereto, other appropriate personal and financial data about you such as home and business addresses and other
contact information, and any other information that might be deemed appropriate by the Company to facilitate the administration of the Plan. By accepting this Grant Agreement, you give explicit consent to the Company to process any such personal
data. You also give explicit consent to the Company to transfer any such personal data outside the country in which you work or are employed, including, if you are not a U.S. resident, to the United States, to transferees that shall include the
Company and other persons who are designated by the Company to administer the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12. By accepting this Grant Agreement, you acknowledge that a copy of
the Plan, the Prospectus, and the Company&#146;s most recent Annual Report and Proxy Statement (the &#147;Prospectus Information&#148;) either have been received by or provided to you, and you consent to receiving the Prospectus Information
electronically, or, in the alternative, agree to contact the Executive Compensation Department of the Company to request a paper copy of the Prospectus Information at no charge. You also represent that you are familiar with the terms and provisions
of the Prospectus Information and hereby accept this Grant Agreement on the terms and subject to the conditions set forth herein and in the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">13. By
accepting this Grant Agreement, you also agree and acknowledge that this Grant Agreement and the Units are subject to the terms and conditions of The Goodyear Tire&nbsp;&amp; Rubber Company Compensation Recovery Policy as amended, supplemented or
replaced from time to time (the &#147;Policy&#148;). In the event it is determined by the Company that any amounts awarded, earned or paid under this Grant Agreement must be forfeited or reimbursed to the Company under the Policy, you will promptly
take any action necessary to effectuate such forfeiture or reimbursement as required by the Policy. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>8
<FILENAME>d776927dex107.htm
<DESCRIPTION>EX-10.7
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.7</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.7 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Restricted Stock Unit Annual Grant Agreement Cliff </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. This
Restricted Stock Unit Annual Grant is granted to you under, and governed by the terms and conditions of, the 2022 Performance Plan of The Goodyear Tire&nbsp;&amp; Rubber Company, adopted effective April&nbsp;11, 2022 (as amended from time to time,
the &#147;Plan&#148;), and this Grant Agreement. As your grant is conveyed and managed online, your online acceptance constitutes your agreement to and acceptance of all terms and conditions of the Plan and this Grant Agreement. You also agree that
you have read and understand the provisions of the Plan and this Grant Agreement. Capitalized terms used but not defined in this Grant Agreement have the meanings set forth in the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. All rights conferred upon you under the provisions of this Grant Agreement are personal to you and no assignee, transferee or other successor in interest
shall acquire any rights or interests whatsoever under this Grant Agreement, which is made exclusively for the benefit of you and the Company, except by will or the laws of descent and distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. As consideration for the Units granted to you hereunder, except as otherwise provided in this Section&nbsp;3 or as may be provided pursuant to
Section&nbsp;14 of the Plan in the event of a Change in Control, you must remain in the continuous employ of the Company or one or more of its Subsidiaries until <B>________, 20__</B> (the &#147;Vesting Date&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. In the event of your death, &#147;Retirement&#148; (defined as termination of employment at any age after 30 or more years, or at age 55 or
older with at least 10 years, of continuous service with the Company and its Subsidiaries) or &#147;Disability&#148; (defined as termination of employment while receiving benefits for a period of not less than one year under a long-term disability
income plan provided by a government or sponsored by the Company or one of its Subsidiaries) prior to the Vesting Date and on any date which is more than six (6)&nbsp;months after the Date of Grant of the granted Units, then, except as otherwise
provided in Section&nbsp;3(b) below, you will receive a prorated number of Units equal to the product of (i)&nbsp;the number of Units subject to this Grant Agreement, multiplied by (ii)&nbsp;a fraction (x)&nbsp;the numerator of which is the number
of days during the period that commences on (and includes) the Date of Grant and ends on (and includes) the date of your termination of employment, and (y)&nbsp;the denominator of which is the number of days during the period that commences on (and
includes) the Date of Grant and ends on (and includes) the day immediately prior to the Vesting Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. In the event of a Change in
Control while this grant is outstanding, the Units shall be subject to the applicable provisions of Section&nbsp;14 of the Plan, and in the event that you incur a Severance (as defined in the Plan, which generally includes certain terminations of
employment within the <FONT STYLE="white-space:nowrap">two-year</FONT> period commencing on a Change in Control) prior to the Vesting Date, the Units shall be deemed to have been fully earned. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. Nothing contained herein shall restrict the right of the Company or any of its Subsidiaries or affiliates to terminate your employment at
any time, with or without cause. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. In the event your employment with the Company and its Subsidiaries is terminated for any reason whatsoever (whether
voluntarily or involuntarily) and within 18 months after such termination date you accept employment with a competitor of, or otherwise engage in competition with, the Company, the Committee, in its sole discretion, may require you to return, or (if
not received) to forfeit, to the Company the payments made (or to be made) hereunder which you have received (or will receive) at any time on or after the date which is six months prior to the date of termination of your employment with the Company.
Additionally, all Units granted to you hereunder which are outstanding shall be automatically cancelled upon commencement of your competitive engagement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Restricted Stock Unit Annual Grant Agreement Cliff </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. The Company will pay to you 100% of the total number of whole Units earned in shares of Common Stock (with
each Unit being equivalent to one share of Common Stock), less such withholding and payroll taxes as the Company shall determine to be necessary or appropriate. Any payment pursuant to Section&nbsp;5 of this Grant Agreement shall be made
(i)&nbsp;within 30 days after a Vesting Date; or (ii)&nbsp;in the event of your earlier termination of employment due to death, Disability or Severance, within 30 days after your termination of employment. The number of Units earned will always be
rounded down to the nearest whole number, and the Company will not be obligated to issue any fractional shares of Common Stock (or pay any cash in lieu thereof) pursuant to this Grant Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. Each Unit will be credited with one Dividend Equivalent on each date on which cash dividends are paid on shares of the Common Stock (and each fraction of a
Unit shall be credited with a like fraction of a Dividend Equivalent). Dividend Equivalents (and fractions thereof, if any) will be automatically translated into Units by dividing the dollar amount of such Dividend Equivalents by the Fair Market
Value of the Common Stock on the date the relevant Dividend Equivalents are accrued to your account. The number of Units (and any fractions thereof) resulting will be credited to your account (in lieu of the dollar amount of such Dividend
Equivalent) and shall continually be denominated in Units, and shall remain unvested, until vested and converted for payment as provided in this Grant Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7. You will be required to satisfy all Federal, state and local tax and payroll withholding obligations, and any other withholding obligations, arising in
respect of any distribution of, or right to receive any distribution of, shares of Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. Any notice to you under this Grant Agreement shall be
sufficient if in writing and if delivered to you or mailed to you at the address on record in the Executive Compensation Department. Any notice to the Company under this Grant Agreement shall be sufficient if in writing and if delivered to the
Executive Compensation Department of the Company in Akron, Ohio, or mailed by registered mail directed to the Company for the attention of the Executive Compensation Department at 200 Innovation Way, Akron, Ohio 44316-0001. Either you or the Company
may, by written notice, change the address. This Grant Agreement shall be construed and shall take effect in accordance with the laws of the State of Ohio. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9. The obligations of the Company under this Grant Agreement will be merely that of an unfunded and unsecured promise of the Company to deliver shares of
Common Stock in the future, and your rights will be no greater than that of an unsecured general creditor. No assets of the Company will be held or set aside as security for the obligations of the Company under this Grant Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10. It is intended that this Grant Agreement shall either be exempt from the application of, or comply with, the requirements of Section&nbsp;409A of the
Code. This Grant Agreement shall be construed, administered and governed in a manner that effects such intent, and the Committee shall not take any action that would be inconsistent with such intent. Without limiting the foregoing, the Units shall
not be deferred, accelerated, extended, paid out, settled, adjusted, substituted, exchanged or modified in a manner that would cause the award to fail to satisfy the conditions of an applicable exception from the requirements of Section&nbsp;409A of
the Code or otherwise would subject you to the additional tax imposed under Section&nbsp;409A of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding anything contained in this
Grant Agreement to the contrary, if you are a &#147;specified employee,&#148; within the meaning of Section&nbsp;409A of the Code, with December&nbsp;31 being the specified employee identification date and the following January&nbsp;1 being the
specified employee effective date, on the date you incur a separation from service, then to the extent required in order to comply with Section&nbsp;409A of the Code, all payments under this Grant Agreement that constitute a &#147;deferral of
compensation&#148; within the meaning of Section&nbsp;409A of the Code, that are provided as a result of a separation from service and that would otherwise be paid during the first six months following such separation from service shall be
accumulated through and paid on the first business day that is more than six months following your separation from service (or, if you die during such <FONT STYLE="white-space:nowrap">six-month</FONT> period, within 90 days after your death).
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Restricted Stock Unit Annual Grant Agreement Cliff </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
You will be deemed to have a &#147;separation from service&#148; on the date of your termination, if after the date of your termination you are not reasonably anticipated to provide a level of
bona fide services to the Company or any affiliate that exceeds 25% of the average level of bona fide services provided by you in the immediately preceding 36 months (or, if less, the full period of services to the Company or any affiliate). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11. In order to administer the Plan, the Company may process personal data about you. Such data includes, but is not limited to, the information provided in
this Grant Agreement and any changes thereto, other appropriate personal and financial data about you such as home and business addresses and other contact information, and any other information that might be deemed appropriate by the Company to
facilitate the administration of the Plan. By accepting this Grant Agreement, you give explicit consent to the Company to process any such personal data. You also give explicit consent to the Company to transfer any such personal data outside the
country in which you work or are employed, including, if you are not a U.S. resident, to the United States, to transferees that shall include the Company and other persons who are designated by the Company to administer the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12. By accepting this Grant Agreement, you acknowledge that a copy of the Plan, the Prospectus, and the Company&#146;s most recent Annual Report and Proxy
Statement (the &#147;Prospectus Information&#148;) either have been received by or provided to you, and you consent to receiving the Prospectus Information electronically, or, in the alternative, agree to contact the Executive Compensation
Department of the Company to request a paper copy of the Prospectus Information at no charge. You also represent that you are familiar with the terms and provisions of the Prospectus Information and hereby accept this Grant Agreement on the terms
and subject to the conditions set forth herein and in the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">13. By accepting this Grant Agreement, you also agree and acknowledge that this Grant
Agreement and the Units are subject to the terms and conditions of The Goodyear Tire&nbsp;&amp; Rubber Company Compensation Recovery Policy as amended, supplemented or replaced from time to time (the &#147;Policy&#148;). In the event it is
determined by the Company that any amounts awarded, earned or paid under this Grant Agreement must be forfeited or reimbursed to the Company under the Policy, you will promptly take any action necessary to effectuate such forfeiture or reimbursement
as required by the Policy. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.8
<SEQUENCE>9
<FILENAME>d776927dex108.htm
<DESCRIPTION>EX-10.8
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.8</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.8 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Restricted Stock Unit Annual Grant Agreement Ratable </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. This
Restricted Stock Unit Annual Grant is granted to you under, and governed by the terms and conditions of, the 2022 Performance Plan of The Goodyear Tire&nbsp;&amp; Rubber Company, adopted effective April&nbsp;11, 2022 (as amended from time to time,
the &#147;Plan&#148;), and this Grant Agreement. As your grant is conveyed and managed online, your online acceptance constitutes your agreement to and acceptance of all terms and conditions of the Plan and this Grant Agreement. You also agree that
you have read and understand the provisions of the Plan and this Grant Agreement. Capitalized terms used but not defined in this Grant Agreement have the meanings set forth in the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. All rights conferred upon you under the provisions of this Grant Agreement are personal to you and no assignee, transferee or other successor in interest
shall acquire any rights or interests whatsoever under this Grant Agreement, which is made exclusively for the benefit of you and the Company, except by will or the laws of descent and distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. As consideration for the Units granted to you hereunder, except as otherwise provided in this Section&nbsp;3 or as may be provided pursuant to
Section&nbsp;14 of the Plan in the event of a Change in Control, you must remain in the continuous employ of the Company or one or more of its Subsidiaries until <B>_______, 20__ </B>with respect to <FONT STYLE="white-space:nowrap">one-third</FONT>
of the Units granted; <B>_______, 20__ </B>with respect to <FONT STYLE="white-space:nowrap">one-third</FONT> of the Units granted; and <B>_______, 20__ </B>with respect to <FONT STYLE="white-space:nowrap">one-third</FONT> of the Units granted (each
a &#147;Vesting Date&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. In the event of your death, &#147;Retirement&#148; (defined as termination of employment at any age after
30 or more years, or at age 55 or older with at least 10 years, of continuous service with the Company and its Subsidiaries) or &#147;Disability&#148; (defined as termination of employment while receiving benefits for a period of not less than one
year under a long-term disability income plan provided by a government or sponsored by the Company or one of its Subsidiaries) prior to a Vesting Date and on any date which is more than six (6)&nbsp;months after the Date of Grant of the granted
Units, then, except as otherwise provided in Section&nbsp;3(b) below, you will receive a prorated number of Units with respect to each Vesting Date that occurs after your termination of employment equal to (i)&nbsp;the number of Units that would
have become vested under this Grant Agreement had you remained continuously employed with the Company or a Subsidiary through that Vesting Date, multiplied by (ii)&nbsp;a fraction (x)&nbsp;the numerator of which is the number of days during the
period that commences on (and includes) the Date of Grant and ends on (and includes) the date of your termination of employment, and (y)&nbsp;the denominator of which is the number of days during the period that commences on (and includes) the Date
of Grant and ends on (and includes) the day immediately prior to that Vesting Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. In the event of a Change in Control while this
grant is outstanding, the Units shall be subject to the applicable provisions of Section&nbsp;14 of the Plan, and in the event that you incur a Severance (as defined in the Plan, which generally includes certain terminations of employment within the
<FONT STYLE="white-space:nowrap">two-year</FONT> period commencing on a Change in Control) prior to a Vesting Date, the Units shall be deemed to have been fully earned. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. Nothing contained herein shall restrict the right of the Company or any of its Subsidiaries or affiliates to terminate your employment at
any time, with or without cause. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. In the event your employment with the Company and its Subsidiaries is terminated for any reason whatsoever (whether
voluntarily or involuntarily) and within 18 months after such termination date you accept employment with a competitor of, or otherwise engage in competition with, the Company, the Committee, in its sole discretion, may require you to return, or (if
not received) to forfeit, to the Company the payments made (or to be made) hereunder which you have received (or will receive) at any time on or after the date which is six months prior to the date of termination of your employment with the Company.
Additionally, all Units granted to you hereunder which are outstanding shall be automatically cancelled upon commencement of your competitive engagement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Restricted Stock Unit Annual Grant Agreement Ratable </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. The Company will pay to you 100% of the total number of whole Units earned in shares of Common Stock (with
each Unit being equivalent to one share of Common Stock), less such withholding and payroll taxes as the Company shall determine to be necessary or appropriate. Any payment pursuant to Section&nbsp;5 of this Grant Agreement shall be made
(i)&nbsp;within 30 days after a Vesting Date; or (ii)&nbsp;in the event of your earlier termination of employment due to death, Disability or Severance, within 30 days after your termination of employment. The number of Units earned will always be
rounded down to the nearest whole number, and the Company will not be obligated to issue any fractional shares of Common Stock (or pay any cash in lieu thereof) pursuant to this Grant Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. Each Unit will be credited with one Dividend Equivalent on each date on which cash dividends are paid on shares of the Common Stock (and each fraction of a
Unit shall be credited with a like fraction of a Dividend Equivalent). Dividend Equivalents (and fractions thereof, if any) will be automatically translated into Units by dividing the dollar amount of such Dividend Equivalents by the Fair Market
Value of the Common Stock on the date the relevant Dividend Equivalents are accrued to your account. The number of Units (and any fractions thereof) resulting will be credited to your account (in lieu of the dollar amount of such Dividend
Equivalent) and shall continually be denominated in Units, and shall remain unvested, until vested and converted for payment as provided in this Grant Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7. You will be required to satisfy all Federal, state and local tax and payroll withholding obligations, and any other withholding obligations, arising in
respect of any distribution of, or right to receive any distribution of, shares of Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. Any notice to you under this Grant Agreement shall be
sufficient if in writing and if delivered to you or mailed to you at the address on record in the Executive Compensation Department. Any notice to the Company under this Grant Agreement shall be sufficient if in writing and if delivered to the
Executive Compensation Department of the Company in Akron, Ohio, or mailed by registered mail directed to the Company for the attention of the Executive Compensation Department at 200 Innovation Way, Akron, Ohio 44316-0001. Either you or the Company
may, by written notice, change the address. This Grant Agreement shall be construed and shall take effect in accordance with the laws of the State of Ohio. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9. The obligations of the Company under this Grant Agreement will be merely that of an unfunded and unsecured promise of the Company to deliver shares of
Common Stock in the future, and your rights will be no greater than that of an unsecured general creditor. No assets of the Company will be held or set aside as security for the obligations of the Company under this Grant Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10. It is intended that this Grant Agreement shall either be exempt from the application of, or comply with, the requirements of Section&nbsp;409A of the
Code. This Grant Agreement shall be construed, administered and governed in a manner that effects such intent, and the Committee shall not take any action that would be inconsistent with such intent. Without limiting the foregoing, the Units shall
not be deferred, accelerated, extended, paid out, settled, adjusted, substituted, exchanged or modified in a manner that would cause the award to fail to satisfy the conditions of an applicable exception from the requirements of Section&nbsp;409A of
the Code or otherwise would subject you to the additional tax imposed under Section&nbsp;409A of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding anything contained in this
Grant Agreement to the contrary, if you are a &#147;specified employee,&#148; within the meaning of Section&nbsp;409A of the Code, with December&nbsp;31 being the specified employee identification date and the following January&nbsp;1 being the
specified employee effective date, on the date you incur a separation from service, then to the extent required in order to comply with Section&nbsp;409A of the Code, all payments under this Grant Agreement that constitute a &#147;deferral of
compensation&#148; within the meaning of Section&nbsp;409A of the Code, that are provided as a result of a separation from service and that would otherwise be paid during the first six months following such separation from service shall
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Restricted Stock Unit Annual Grant Agreement Ratable </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
be accumulated through and paid on the first business day that is more than six months following your separation from service (or, if you die during such
<FONT STYLE="white-space:nowrap">six-month</FONT> period, within 90 days after your death). You will be deemed to have a &#147;separation from service&#148; on the date of your termination, if after the date of your termination you are not
reasonably anticipated to provide a level of bona fide services to the Company or any affiliate that exceeds 25% of the average level of bona fide services provided by you in the immediately preceding 36 months (or, if less, the full period of
services to the Company or any affiliate). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11. In order to administer the Plan, the Company may process personal data about you. Such data includes, but
is not limited to the information provided in this Grant Agreement and any changes thereto, other appropriate personal and financial data about you such as home and business addresses and other contact information, and any other information that
might be deemed appropriate by the Company to facilitate the administration of the Plan. By accepting this Grant Agreement, you give explicit consent to the Company to process any such personal data. You also give explicit consent to the Company to
transfer any such personal data outside the country in which you work or are employed, including, if you are not a U.S. resident, to the United States, to transferees that shall include the Company and other persons who are designated by the Company
to administer the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12. By accepting this Grant Agreement, you acknowledge that a copy of the Plan, the Prospectus, and the Company&#146;s most
recent Annual Report and Proxy Statement (the &#147;Prospectus Information&#148;) either have been received by or provided to you, and you consent to receiving the Prospectus Information electronically, or, in the alternative, agree to contact the
Executive Compensation Department of the Company to request a paper copy of the Prospectus Information at no charge. You also represent that you are familiar with the terms and provisions of the Prospectus Information and hereby accept this Grant
Agreement on the terms and subject to the conditions set forth herein and in the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">13. By accepting this Grant Agreement, you also agree and
acknowledge that this Grant Agreement and the Units are subject to the terms and conditions of The Goodyear Tire&nbsp;&amp; Rubber Company Compensation Recovery Policy as amended, supplemented or replaced from time to time (the &#147;Policy&#148;).
In the event it is determined by the Company that any amounts awarded, earned or paid under this Grant Agreement must be forfeited or reimbursed to the Company under the Policy, you will promptly take any action necessary to effectuate such
forfeiture or reimbursement as required by the Policy. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.9
<SEQUENCE>10
<FILENAME>d776927dex109.htm
<DESCRIPTION>EX-10.9
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.9</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.9 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Restricted Stock Unit Continuous Vesting Grant Agreement </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.
This Restricted Stock Unit Annual Grant is granted to you under, and governed by the terms and conditions of, the 2022 Performance Plan of The Goodyear Tire&nbsp;&amp; Rubber Company, adopted effective April&nbsp;11, 2022 (as amended from time to
time, the &#147;Plan&#148;), and this Grant Agreement. As your grant is conveyed and managed online, your online acceptance constitutes your agreement to and acceptance of all terms and conditions of the Plan and this Grant Agreement. You also agree
that you have read and understand the provisions of the Plan and this Grant Agreement. Capitalized terms used but not defined in this Grant Agreement have the meanings set forth in the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. All rights conferred upon you under the provisions of this Grant Agreement are personal to you and no assignee, transferee or other successor in interest
shall acquire any rights or interests whatsoever under this Grant Agreement, which is made exclusively for the benefit of you and the Company, except by will or the laws of descent and distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. As consideration for the Units granted to you hereunder, except as otherwise provided in this Section&nbsp;3 or as may be provided pursuant to
Section&nbsp;14 of the Plan in the event of a Change in Control, you must remain in the continuous employ of the Company or one or more of its Subsidiaries until _______<B>, 20__</B> (the &#147;Vesting Date&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. In the event of your death, &#147;Retirement&#148; (defined as termination of employment at any age after 30 or more years, or at age 55 or
older with at least 10 years, of continuous service with the Company and its Subsidiaries) or &#147;Disability&#148; (defined as termination of employment while receiving benefits for a period of not less than one year under a long-term disability
income plan provided by a government or sponsored by the Company or one of its Subsidiaries) prior to the Vesting Date and on any date which is more than six (6)&nbsp;months after the Date of Grant of the granted Units, then, except as otherwise
provided in Sections 3(b) or (c)&nbsp;below, you will receive a prorated number of Units equal to the product of (i)&nbsp;the number of Units subject to this Grant Agreement, multiplied by (ii)&nbsp;a fraction (x)&nbsp;the numerator of which is the
number of days during the period that commences on (and includes) the Date of Grant and ends on (and includes) the date of your termination of employment, and (y)&nbsp;the denominator of which is the number of days during the period that commences
on (and includes) the Date of Grant and ends on (and includes) the day immediately prior to the Vesting Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. In the event of your
death, Retirement or Disability prior to the Vesting Date and on or after <B>December</B><B></B><B>&nbsp;31, ____</B>, the Units granted to you hereunder will be deemed to be fully vested, which Units will be payable as provided in Section&nbsp;5.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. In the event of a Change in Control while this grant is outstanding, the Units shall be subject to the applicable provisions of
Section&nbsp;14 of the Plan, and in the event that you incur a Severance (as defined in the Plan, which generally includes certain terminations of employment within the <FONT STYLE="white-space:nowrap">two-year</FONT> period commencing on a Change
in Control) prior to the Vesting Date, the Units shall be deemed to have been fully earned. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">d. Nothing contained herein shall restrict
the right of the Company or any of its Subsidiaries or affiliates to terminate your employment at any time, with or without cause. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. In the event your
employment with the Company and its Subsidiaries is terminated for any reason whatsoever (whether voluntarily or involuntarily) and within 18 months after such termination date you accept employment with a competitor of, or otherwise engage in
competition with, the Company, the Committee, in its sole discretion, may require you to return, or (if not received) to forfeit, to the Company the payments made (or to be made) hereunder which you have received (or will receive) at any time on or
after the date which is six months prior to the date of termination of your employment with the Company. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Restricted Stock Unit Continuous Vesting Grant Agreement </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Additionally, all Units granted to you hereunder which are outstanding shall be automatically cancelled upon commencement of your competitive engagement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. The Company will pay to you 100% of the total number of whole Units earned in shares of Common Stock (with each Unit being equivalent to one share of
Common Stock), less such withholding and payroll taxes as the Company shall determine to be necessary or appropriate. Any payment pursuant to Section&nbsp;5 of this Grant Agreement shall be made (i)&nbsp;within 30 days after a Vesting Date; or
(ii)&nbsp;in the event of your earlier termination of employment due to death, Disability or Severance, within 30 days after your termination of employment. The number of Units earned will always be rounded down to the nearest whole number, and the
Company will not be obligated to issue any fractional shares of Common Stock (or pay any cash in lieu thereof) pursuant to this Grant Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. Each
Unit will be credited with one Dividend Equivalent on each date on which cash dividends are paid on shares of the Common Stock (and each fraction of a Unit shall be credited with a like fraction of a Dividend Equivalent). Dividend Equivalents (and
fractions thereof, if any) will be automatically translated into Units by dividing the dollar amount of such Dividend Equivalents by the Fair Market Value of the Common Stock on the date the relevant Dividend Equivalents are accrued to your account.
The number of Units (and any fractions thereof) resulting will be credited to your account (in lieu of the dollar amount of such Dividend Equivalent) and shall continually be denominated in Units, and shall remain unvested, until vested and
converted for payment as provided in this Grant Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7. You will be required to satisfy all Federal, state and local tax and payroll withholding
obligations, and any other withholding obligations, arising in respect of any distribution of, or right to receive any distribution of, shares of Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. Any notice to you under this Grant Agreement shall be sufficient if in writing and if delivered to you or mailed to you at the address on record in the
Executive Compensation Department. Any notice to the Company under this Grant Agreement shall be sufficient if in writing and if delivered to the Executive Compensation Department of the Company in Akron, Ohio, or mailed by registered mail directed
to the Company for the attention of the Executive Compensation Department at 200 Innovation Way, Akron, Ohio 44316-0001. Either you or the Company may, by written notice, change the address. This Grant Agreement shall be construed and shall take
effect in accordance with the laws of the State of Ohio. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9. The obligations of the Company under this Grant Agreement will be merely that of an unfunded
and unsecured promise of the Company to deliver shares of Common Stock in the future, and your rights will be no greater than that of an unsecured general creditor. No assets of the Company will be held or set aside as security for the obligations
of the Company under this Grant Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10. It is intended that this Grant Agreement shall either be exempt from the application of, or comply with,
the requirements of Section&nbsp;409A of the Code. This Grant Agreement shall be construed, administered and governed in a manner that effects such intent, and the Committee shall not take any action that would be inconsistent with such intent.
Without limiting the foregoing, the Units shall not be deferred, accelerated, extended, paid out, settled, adjusted, substituted, exchanged or modified in a manner that would cause the award to fail to satisfy the conditions of an applicable
exception from the requirements of Section&nbsp;409A of the Code or otherwise would subject you to the additional tax imposed under Section&nbsp;409A of the Code. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Restricted Stock Unit Continuous Vesting Grant Agreement </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding anything contained in this Grant Agreement to the contrary, if you are a &#147;specified
employee,&#148; within the meaning of Section&nbsp;409A of the Code, with December&nbsp;31 being the specified employee identification date and the following January&nbsp;1 being the specified employee effective date, on the date you incur a
separation from service, then to the extent required in order to comply with Section 409A of the Code, all payments under this Grant Agreement that constitute a &#147;deferral of compensation&#148; within the meaning of Section&nbsp;409A of the
Code, that are provided as a result of a separation from service and that would otherwise be paid during the first six months following such separation from service shall be accumulated through and paid on the first business day that is more than
six months following your separation from service (or, if you die during such <FONT STYLE="white-space:nowrap">six-month</FONT> period, within 90 days after your death). You will be deemed to have a &#147;separation from service&#148; on the date of
your termination, if after the date of your termination you are not reasonably anticipated to provide a level of bona fide services to the Company or any affiliate that exceeds 25% of the average level of bona fide services provided by you in the
immediately preceding 36 months (or, if less, the full period of services to the Company or any affiliate). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11. In order to administer the Plan, the
Company may process personal data about you. Such data includes, but is not limited to, the information provided in this Grant Agreement and any changes thereto, other appropriate personal and financial data about you such as home and business
addresses and other contact information, and any other information that might be deemed appropriate by the Company to facilitate the administration of the Plan. By accepting this Grant Agreement, you give explicit consent to the Company to process
any such personal data. You also give explicit consent to the Company to transfer any such personal data outside the country in which you work or are employed, including, if you are not a U.S. resident, to the United States, to transferees that
shall include the Company and other persons who are designated by the Company to administer the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12. By accepting this Grant Agreement, you
acknowledge that a copy of the Plan, the Prospectus, and the Company&#146;s most recent Annual Report and Proxy Statement (the &#147;Prospectus Information&#148;) either have been received by or provided to you, and you consent to receiving the
Prospectus Information electronically, or, in the alternative, agree to contact the Executive Compensation Department of the Company to request a paper copy of the Prospectus Information at no charge. You also represent that you are familiar with
the terms and provisions of the Prospectus Information and hereby accept this Grant Agreement on the terms and subject to the conditions set forth herein and in the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">13. By accepting this Grant Agreement, you also agree and acknowledge that this Grant Agreement and the Units are subject to the terms and conditions of The
Goodyear Tire&nbsp;&amp; Rubber Company Compensation Recovery Policy as amended, supplemented or replaced from time to time (the &#147;Policy&#148;). In the event it is determined by the Company that any amounts awarded, earned or paid under this
Grant Agreement must be forfeited or reimbursed to the Company under the Policy, you will promptly take any action necessary to effectuate such forfeiture or reimbursement as required by the Policy. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>gt-20240226.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 2/29/2024 10:18:31 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2023"
  xmlns:gt="http://corporate.goodyear.com/20240226"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://corporate.goodyear.com/20240226"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" namespace="http://xbrl.sec.gov/naics/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gt-20240226_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gt-20240226_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://corporate.goodyear.com//20240226/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>gt-20240226_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 2/29/2024 10:18:31 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>gt-20240226_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 2/29/2024 10:18:31 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://corporate.goodyear.com//20240226/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="gt-20240226.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://corporate.goodyear.com//20240226/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140401958279536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Feb. 26, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">GOODYEAR TIRE & RUBBER CO /OH/<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000042582<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 26,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">OH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-1927<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">34-0253240<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">200 Innovation Way<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Akron<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">OH<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">44316-0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(330)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">796-2121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, Without Par Value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>16
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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ML0(  .(,   -    >&PO<W1Y;&5S+GAM;-U7;6O;,!#^*T(_8&YB:N*1&+9
M8;"-0O-A7Y58=@1Z\62Y<_KKI[-L)VEU9=V'L<VAR=T]NKM'=R>9KEMWDOSA
MR+DCO9*ZW="C<\W[)&D/1ZY8^\XT7'ND,E8QYU5;)VUC.2M;<%(R6=[<9(EB
M0M-BK3MUIUQ+#J;3;D-O:%*L*Z//EI0&@U_*%">/3&[HEDFQMV)8RY20IV!>
M@N%@I+'$>2I\0Q=@:9\"O @:L!SC**&-!6,2,H3O_;C\&3!IK5>%E#/!)0V&
M8MTPY[C5=UX9%@_&%Q 9Y=VI\0QKRTZ+Y2T].PP_/LG>V)+;.<V"3J9B+7D%
M=*RHC_#K3), Z)Q17B@%JXUF X?)8Q1\V .7\@%:^*VZBMU7)/3B4PEM(+#5
M2?2$1C&$"0K$OXP68E^$O?VML*01C\9][/QN]*!_[XSC]Y97HA_TOIKS8]$7
M>'36-/+T08I:*Q[V_LL)BS6;_,C16/'DL\&D'+R!6TH>N77B<&GY85FSX[V;
MIJFO<,[+?Y#SGZUSS36W3%Z2]J/_-U?Y+8R3\?1<'-&K SI;"5R$&_H5[E=Y
MYD#VG9!.Z%$[BK+D^L4Y]>$=V_L+_"J^7U_RBG72[69P0\_R%UZ*3N7SJGNH
MR[CJ+'^&^VB1S;>PSR5TR7M>;D?5UOM!)%[P6<<'')XC=\,31S"?@,41P+ \
M& /,)WAA>?ZG_:S0_00,X[:*(BO49X7Z!*\8LAT^6)ZX3^Z?^$[S/$VS#*OH
M=AMEL,7JEF7P%X^&<0,/+ ]D>ENM\6[C$_+Z'& ]?6U"L)WBDXCM%*\U(/&Z
M@4>>Q[N-Y0$/K O8[$#^>!Z8J;A/FD)7,6[8"<:1/,<0F,7XC&894IT,/O'^
M8*<D3?,\C@ 69Y"F& *G$4<P!L !0])T> \^>Q\ETWLJ.?]74_P$4$L#!!0
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M8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ >GA=6)E<G",0!@  G"<  !,
M             ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M" !Z>%U83JKV<%($  "0$   &               @($."   >&PO=V]R:W-H
M965T<R]S:&5E=#$N>&UL4$L! A0#%     @ >GA=6)^@&_"Q @  X@P   T
M             ( !E@P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !Z>%U8
MEXJ[',     3 @  "P              @ %R#P  7W)E;',O+G)E;'-02P$"
M% ,4    " !Z>%U8'#AEZC\!   \ @  #P              @ %;$   >&PO
M=V]R:V)O;VLN>&UL4$L! A0#%     @ >GA=6"0>FZ*M    ^ $  !H
M         ( !QQ$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#
M%     @ >GA=6&60>9(9 0  SP,  !,              ( !K!(  %M#;VYT
D96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  ]A,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d776927d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corporate.goodyear.com//20240226/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d776927d8k.htm">d776927d8k.htm</File>
    <File>gt-20240226.xsd</File>
    <File>gt-20240226_lab.xml</File>
    <File>gt-20240226_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>23
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d776927d8k.htm": {
   "nsprefix": "gt",
   "nsuri": "http://corporate.goodyear.com/20240226",
   "dts": {
    "inline": {
     "local": [
      "d776927d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "gt-20240226.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "gt-20240226_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "gt-20240226_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://corporate.goodyear.com//20240226/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2024-02-26_to_2024-02-26",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d776927d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2024-02-26_to_2024-02-26",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d776927d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://corporate.goodyear.com//20240226/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://corporate.goodyear.com//20240226/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://corporate.goodyear.com//20240226/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://corporate.goodyear.com//20240226/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://corporate.goodyear.com//20240226/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://corporate.goodyear.com//20240226/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://corporate.goodyear.com//20240226/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://corporate.goodyear.com//20240226/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://corporate.goodyear.com//20240226/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://corporate.goodyear.com//20240226/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://corporate.goodyear.com//20240226/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://corporate.goodyear.com//20240226/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://corporate.goodyear.com//20240226/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://corporate.goodyear.com//20240226/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://corporate.goodyear.com//20240226/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://corporate.goodyear.com//20240226/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://corporate.goodyear.com//20240226/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://corporate.goodyear.com//20240226/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://corporate.goodyear.com//20240226/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://corporate.goodyear.com//20240226/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://corporate.goodyear.com//20240226/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://corporate.goodyear.com//20240226/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>24
<FILENAME>0001193125-24-053163-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-053163-xbrl.zip
M4$L#!!0    ( 'IX75B'EU<7+P\  +MI   .    9#<W-CDR-V0X:RYH=&WM
M76USVKH2_IY?H:'3-ID)&!OR B2<H82V3-,D%]+3<^Z7CK %Z-98KB0G<'_]
M7<DOF+=  B'IN;33!*.5M-I]M-I=R>K9'\.!B^X(%Y1YY^_-7/X](I[-'.KU
MSM_7VO5F\_T?U;VSO@0R(/5$V2'T/-.7TB\;QK##W9P@=J['[@PH,*R\5<A$
MA('(RI%/1$+=Q:*38[QGQ"43Y![SO&"0$-_?W^=T\ZJ"([FA:AA E 4JPJD=
MUQNZU/LY4>V^H"N9I5+)T*4QZ0QETH&5SQ<,5=S!@L3D/9D0VXS[C&-)8*3,
M&1',<S8;*/Z+><LZ3G@1=!XGT+II_/7ULFWWR0!GJ2<D]NRDGT#RA5R5#"B-
M":E@1<L\>6 ($4528;B(U@1:#P9,_OK0NAR3R_GT8U)#<NR)+N,#+ $RJJ6C
M;-[*CF4 C60!$A,-Q1!9ULYIMF FLH3.Z4-#G9*B*G6FH!D1'QMA842Z&"P*
MYAD%=X(=^"6I=$GU-/OES @_[IT-B,1(5<^27P&].\_4F2>))[.W ,\,LL.G
M\XPD0VGHY@RH980-(H3..@"?ZIE#[Y"0(Y><9QPJ?!>/%/Y)IHK.Z+"LJ F/
M/E/'(5[X&4BN0O CZIQG/NNB'S#O?C0\8'#4(CTJE&#E%1X -Q[\A X(+<\O
MU]P.98MT@2K@6A,_%*9#C?Z0+/64J7ZZOK[XNU%KH=MFJX'>X8%?0:UO'SXT
M6JA^C8SKS\:9,<'E#-=CAFH#XCGP3WYT<>^QG.C1T^$=H,7*5+O8%619SW/E
M58?^.7:;GD.&7\AH5F S!(^46%[]*5I'I]8L?\:4<CGI$@ZVEPAX5J:H++2Y
M@+Z>T]+IGI1M/<\(.O#=Y+L^5X/LR6QLY')#X<2%F-N<*?0N[\*(QCHQ/OTL
M6,##1SW7RY%PM:Y6$&Y<C6A5)8_445]T*>%("Y#,M43UYI=)]4Q75ES/;=\'
M_3$G>00CQ.4%K S5,6]QS7'9F%=G 6U<DG2;]&-,2">1YEAZ1MID&&!:X%?*
MP*A:6>S2GE>V82R$9R;+[ZDC^^73W!'U*BE:EW1E98!YCWI9];F,<"!9_ VG
MO7[TE6K.CQM3]CW;)[H4O D_:4(ROYQZ[# IV4!_TV$<6(^_,?TA$LRE#GJC
MU9//5-^],8_SE3/#7]1187E'UI,[2C5;A$;0[ !0%U23%?2_I&R>)L]=/*#N
MJ'Q+!T2@*W*/6FR O8HNNP_Y[C#7J<Q1S[>KYFWC K5O:[>-]F)V\EMBI]VH
M?VLU;YN--JI=7:#&7_7/M:M/#3#Z7[\VV^WF]=5:/%J;X/$[%GWP627S#M%%
MKIY#5OZH6)KB*]7I*LB<!,2R&347F<=/0F8N#V23X*R$L]0RW\Z.?L59.AY,
M;"3F*<S<%JH^@N^WV#^X8':@W(.46_4$]P"BB]!]FUQ\=[!X%EAL9"+7 PY>
M@D0M @&7?'G#<A-P$8#'C"1#;6(KY"&S@!A'YM&^<_#R#+(NDGVB> LXE13J
M-X9V'WL]@FJV1%!LE@K%Q7QN3;/*O5'LA)I%^_$S!-,NL"T1N5.*Y[J8. ?E
M=V].S5*Q<B9\[$W,U05,I#E6TW3_S%!5JTN-S(UVM1JA!_9H:Q,&L<KBR+(#
M#0R@>M_!(Y4E(%[:&A7!ZI$.#S ?(>OX$*E69FS34T=[$(]V'40NT_,<M4XP
M;#.7\?*;KJW^9N8,)H613/6KDA0R0T&@A/]YP]C9Z(W8:*NXB9F,)O2*5+HG
M2X?9,)HM+TM+5&\_-]"#N82O-[6KOR,<H+7PG-_$</<;0PR65-D-9:]X,AR$
M!1(^L57 Z"#J(2H% ML+YHM/KPP[ "\ \#J"V3N3N.,29!/7!;38*FN=R6?T
MLX\=)WZ.NHJ&"D;*Q;X@Y?C#PQ!)X4DYOJ$PS'S^;22Z<C[BLIR/XV'@B^N?
MSF2072B^5?F0=,$=X9+:V(VD&@YTFBBJ;:U6.V9QACK=S)D1L<CC4A_W2+;#
M"?ZI,M34(65\QP %*TO'U.J9Z!&E (,F$%/66$%3 P"U+UTU%B[GH;5I>G&R
M'I;MMH0%N<X"3_)1G3EK+>[*S*F4CB0^9W>JV\G5_2A3O>Y3-AML1.N9=%;1
M? +O:?(7$.5'ZA(HZX"1>7H(=IRIFEFS9)W\@P1SBX?-*%-H:TFL+:633+6@
MOCX"+S'_D*2>8=Z>;F7:[NNYJ (G!O$*1_^!<$4X5$=49QUNJ$"&IN?NP6L&
MR'Z=#094B)AY-550B(*7Y?NIKM)&<CK[S5PKU\ZAQL!WV8CP1_ENYC,P-#E+
MT17+'81.2#R3X(?R('Y7AT1SN(Y'<I3?B$]1/'V]/D4\S=8S^37'X42(Z-<E
M^-GF&N;^-%.U\GG4]#QV%T+S.QY-F_W#Q>G1"9[J\/&:W[)[;PV.2IEJ[2<'
M:_9$)K1UO^8WX!I1O2O_;(Y6(?^Z'*V-XNN&P<#=?U/_2=[J6$9FIEHL%LSC
M+,1OYC_3GX@DID)RGP/FJ(]=1(;$#B2]4Y$ZF'TB7K<7 8I&2M,',RJ9LS ]
M,FF[D=S'.'?S[LVI99Y4!,C!)7Z?>01YVM\Y5&Z;&ZBU#6& #8 6,+/8;"AS
M50.Z-1%N@?C %ARL?N;DDH%V;A3GZ[KKA4*F>E(ZSEJF-6=R[?(^S["YM S-
MF6J]3^R?>B\$^[!P@$U0\4:'#5&'N.P>T7"C1.\[GF:_H"YU%62I /Q*XCG$
M47L\@@X"5V*/L$"X(R0 $Z([TC6C"JP#<@@7[6CO)941#* =CK WBLNZX-*Q
M>U5/+694!0RBO! CQT]U.#?J4"9>Y-BSG'5AIUS<E=:0S%S?\>UBHQLYJ6\K
M<XWKHHG^G5,)&E4A6N!%OK]8VR/I,.9V,&A3 J;2QJ"H^"^=%(N565NP9-&9
M#MG0I/+1VC9^ZD!/IAK)!H21%@[R4]N<K0  5;2.(C!/[2ZJ3<5]\P35/[:0
M5<CG@/ Q,=4.X9M >!OLM WZ\'I?P<B!I7.?#]Y'OQ.\QX*!ID/)S&+;+.*L
M::7@/;%CGH"[F,^%E#M\;QO?-YPHZZV.B^I30&IYYM?=[A.<MI5Q?OP[X1P$
ME+53$EIJS\VBD[7V.P>KH3ZDW>'^A7'?%"(@?"OH/_F=T#\15M_WJ219I5 "
M;-]S[,].C_@PP;)9LK1ALT"RQ7T[CM>7S::E[>GI%K69/L&SS40 K)IC]RZ,
M90B':,B?=_1-VY HMH&1+@YE7G_R?+>;O^$LW@HIA05#G#,S7G3?Z%:][A4>
M3K3[R':Q$,FL?-8DXE-%^-+RXEA-3[T5VAX-@&Q?'.PD]H#$KJ+39!I@)%H[
MPGUP#\%\@&_'IGAR17AU.VQ+8M5P<1F95D=/JS72KJ>9JG*/0$)MR>R?A^@[
ME7T62'2#.?H3N\',>X OE/9?)(MHGH139 U!E#+53[>O?*RQWF/'Z"GOG,[X
MKVJFS.P(%L&)OP5_Y H+!_\*L8&^8OZ32'1Y69\KIZWY5DW/4?XF09T1LG6*
M&EK\"5.<Z&,P4_EC*A XC."SJDY[J,?9O>PKM]57.64LD$.ZU M/FX9YNOP1
MFGT%8'SROX#VE;I/*CI7%Q-3?4[55^=4U8F<%7U?JY.U8L=WM=<.EC<:<Z?\
MX)GV4VSFUGN#8;F>&@MDOF3?-J[V2=>JAY6>+4PKF@^$:<\KGV;W 62J/<"Y
M,*<S.R1] #%Q(9P $'M,!Q>!()H*!!;MPZC+ :@..,+78)6 =%_N2'5^#V9?
M;[)XP!^4<')'!=2#J8$]6^7\L&VK4Y^*6%T3X&#NB' 'QID?V80VT2SLXR2\
M20,ZAQ*Q;VY[[Y_VUFRXQQ?M].WMS0<C&<Q@47V5\F,Z!+0-?HQ[CT<B$[X!
ML'?63UR>Z"63DOY3B4?C#]-)'T,S\/#^Z69?@MZ;SFA]N&Y=-%K9^O7E9>VF
MW2C''UYS1LLTYR:LD/X(\)G-OLP>:FA*,E"'!?)FY2B7MV;/7Z0;>ZF4TD,N
M>CC*"^)C+@.NO?0+RL%,,"Z4M:D#KQC6WVM]PH2+"FJX47HD35I!-=]GU),Z
M/PLEL_74<D$\@8%\A&J<*VNCJ,4\\AQZ3&+H>!,V_]I#\0MKX2R/WUH[U ;R
M<P!4J(Y]*I7)]9SQ@)0P]!%9*0F)#>H'!F9X2IQ=I#RW3]&M.N@62N+7@8).
M!QRD>NS[J$W].Z*7@H&NV O?P>EQ$@EMG(P#'BUT0[A>5SV;H!L7.%6+B+I!
MZ%< BM;O[ CM*C)?IP,/'RH,UQRUE)!!5*(X(K#:Z,%J6P!-^*E.11]S M_9
M6/2SZC(,9Z(X\-3[0DIL0"5A#9=)I[HH-_WNT]0KV.NDVW?&J5+*J9-QOZ=Q
M^I@X.OK<90A_A:3&L$\["796/>=L/7.J=C-H6R%7N[<79FOU+\>(?J^27RTL
MR*^6BDE^-6K\.3,OLTB;FQLU(5AZ9+2_*.:?&])C%-[^XYR<')>L$X<,S;R9
MZ\M!=&T#&-\K,)7_2DQE&')?:U.)/FF[7(OM,B 1+\I>3;W#/,%9?)P-"HR%
M)1 4* #"C+6V=@!]=259VU:2M;*2TLM96%!++V<M)>&=)A--%K:MR<*D)M.^
M3%NY%3O=)+HI;ELWQ66Z49<"4B]@@4!_@FNGLA [=<7J.MJVNHXFU=5(7A%(
M*^X;>-P[)25*.MZVDHY75M)N<CV@MY-MZ^UD4F^M<20;>A5:937/ R\$U<$1
MZ>Z4E2CK=-O*.GV$LEHX#/%VZHK55=JVNDJKJ&MG#A>K[#D]PSJ#;]$-# \U
MU7X"MO5R=0'3!NG; /;)H$,<M=VD8BWJZ<1D4]^ C=05V,B)KA\[&.MF+\G3
M[*4W4_;0WO_A?LJ+7OK4;GZZJMU^:S7:#]Q %5Z,-X<;W2#UU.T#Y>+;1V;=
MTU<.AINGOP+*QQL#*^R['\[;=74"=X1L'*@\M-Y;#Z_:4]UT"!(P>BA@X2U6
M'=+';E=MYJJ&=&(](N@33@(/ZNCF0%=]QF%@SD/9ZM\VOSB=49R$=_%838S5
M<XP+;T]8L9GYM:T-,7'T@HG.^>-[Y/&E[;4Y7O0*2W<<9FZ[BY::Q5?>/7VI
M5A-MP5JMBR87Z\V2O<C2'ZM/7=Q91N/+-4OQY9IKGHC;'J2J'T:;YO9Q]P'I
M0ZY+#GL\<B$SA '^D$>)BVYSZ&\6>+TMGV3]O<W,L^!L1B$[9;R<,L"-XT2"
MR5HE!#@SPO\\1O^_,M7_ 5!+ P04    " !Z>%U8]<F87)X0   T/   $0
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M2B+'3"8FJ>T<;+\L*YO).V=G(]GG4(,,6$6*1R>5RU4-91(/]'/$](@PB(C
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M;":W'!Q,Y#7;&E3 6E-<.:M<KAH8&7C@_TY4SR[1X-F=>#W8>FCRN^/1<:W
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M[1??XK4YJ2@&798.@%'![LUD:;_N%N1[JY7OJN-4MB@IJD]XQ?(A>!V./-5
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M\MK;PN#A'OWJ%C[D'^OZ'U!+ P04    " !Z>%U8#JT<&/X0  #K/0  $0
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M"/7 .?&FX;M-2\1+\A_@A1RF&J.H;")0*55E8\DEZ+ *]\0'HV8MO^$A*"!
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MCE\"MX,!8K:&A;=:5SJX3@YH@=BR\M6VL!V<'I^Y/Q,D=#O@8[&!4Y_Q:9]
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MN:A>N<2,&Q)@(HSS;-"7%&*4EI<Q&X9)&Y6ON33:[!K=.18"6H:0?.\WO.1
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MNZSI>]CTWH/U0J:? :4@4I_XZWS8=IHO8QUC$[VTAFIL5=E*3/"@Z'Q>'2+
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M'P!W0(.:C1/I5=#7.3E4/'X!+)X)&.=DT@I'TB88\AX>G9_&K8[>7YV<7FU
M='M^>'E]NAO_>%!PLU)N"=[F3:O;$L>GY^>7AR<G9Q=OR\_7EX?'\?/'LY.;
M=V]:6]WNCRVFYTHX/TF5>"-:.403&SWPT)\W-"G#KKPU.@D+3^+#SW^L+G5S
M,O/CSH\M\2%$O<"4,@+F6%MVZH_4?YIZJ,YN,<UA\6?U?D_,T'0V WH4(K$^
M7"D/#@I-EY5!K,4( /2=\8+-!1YCC65WZ<FG 3>%', R\:P;=;;9P' 3HA$$
M:D]+=G9(KU/T<'<: @7X/E7288X@XNI!W3B<LK<:T(-6U^T#<6K6(M;!9(B<
M!'2ZYBS1@" VRX33]V+MQ3I+= RGC%P@&[=&2\#C&<KP (A[$1P,4 175O'^
MBU$7+1W1K=FP8(\8-TN$!T 98.*L$^E)1]$L'9R$@TD<RWF]D >R[PN91L<P
M#H(E-S?O01[$?M"D-#5WZ%9(26#S!3OQ;3MBD2HU&Y46X=V =R4'<7' '&8T
M!IK,^Z]AKHB\Q?V6>.;'O"9B&=DQ_.<*_X.8-A4)_8.1WXZ1O;\+1B9*@NV9
M")8GVLF>3K6??!58 B*E*F@P^=X0K3N*023F':!T^!!F8"DD$PQ;& A0ZLZY
M@12IR88;> Y&Z8$2B"S D" BP>BV#$M ^V4H(K!56N$@Y(0L9<HTID*.^5#C
ML8$5(LNO159839)(U5 B"N20.,&%)!4HII#A>Z"NIZ1[-=3E^%+ZZ0+00SA:
MJ5NE:$^ IZNS])O!%@L"?QIM_PE('P5L^W]!L+TP'NV+:F.H(S,9^YI<7]M>
MGZZ2327NL>*&X(?5/M@ H(YTJJ<&E#C9,E=>9(#M*O5C2P<;R($(+A=.A"MF
M<G%^+)1U*+4'\Z=LD2IB/:4@HRS2=%(:B.?";4",L2DJL)"8$PN3Y\;Z FB8
M</Z]ZA57AH1F8Q5,6($381NXUI_B2;A@8,9C!6O835D2K6V>G'V SZ%9TFP(
M^O]^SO8W77!0XSDUQZ]J!LJJM2O3.SEQ:#";.1[R[DI<G_T'S.99*^Y+S9S=
M'U[3_Z81(!K"\>G%S>G5-[9SGK*A\[7=%.+G8E+F*!%U4EY-(S6+YO\;JY._
M)E:/T! Q.Y=DK5@; U-FN\="MM5]1CNJ<2\H:=$_"TI9^--@ (&.Q,Z--\U&
M#,@4QRCS)0?N,Q%2&:XF&("[OBR<6B&0>/0*X\Y,*#=+]4H%# BJ:S=/."W
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M&+HRG\A)D9E\NH7[8$;E*0$;!4,"\\5,I#9<4'[I*SYLE9!40GX *67+,EJ
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MWE9T.'B$_V4&^)+^@P[_ 5!+ P04    " !Z>%U8LNRB8SD1  #S.   $0
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MSL?>=<'HY #?6H0OZ67'_P%02P,$%     @ >GA=6/J:;3:&$0  [3H  !$
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M^-'7^-N5Y!8C62H?E,XR,X_,,)X)T<8JFK2;;E0/TFBCSF((1A?%72)EB;(
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MN%OL?)_/R-M"5-0(6#*<0#(CN/0Y]ZN:4JZ^)*6_/\94!Q('WP&#7DA0Z.#
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M<+I+:^JWR+N<>EO[Y>0!O4F*+_D%U/\'4$L#!!0    ( 'IX75@#T@FK0P,
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MJ^NE>.):'YF_.Y&=HNE?7]!G_@-02P,$%     @ >GA=6-&]^]"[!   ARH
M !,   !G="TR,#(T,#(R-E]P<F4N>&ULU9I=C^(V%(;O5]K_X*8WK=00 K/;
M'33,BC(S*]3Y0,"V56]6)CF 5<=&MAG@W_<XX!6!,(7IMHJYX,/Q>_SZ/([C
MF%Q]7&6</(/23(IV$-?J 0&1R)2):3M8Z)#JA+& :$-%2KD4T [6H(./UV_?
M7'T7AN3FKO=(0C(S9JY;4;1<+FOIA DM^<)@2%U+9!:1,'3UNZ//Y+=-<RTR
M  Y4 \FH-J#(+PO&TU:CWFC&];A1:^S*%% ;CZ340(LTHL9EA!4O2%QOQ1]:
MS9CT'\AM'D:0$<M@5ROG:\6F,T-^2'XDN>I&"@&<PYK<,4%%PB@G0V?Y)](3
M28UT."<#*]/H4X-ZAK2VC<J9^*MEW\;6/7G[AN +$RET7MH.;#JVV5B-%:])
M-46[]6;D1,&N9G4@6C9S27QY>1GE1XOU-2NKC0W$T1\/]\-D!AD-$0)"2_::
M0C>I^:K>-?<NVAQT]35KZ3S2O4SRW)_0+7*TAOT5NFJA+0KC1MB,:RN=!M>V
MR4U6E>0P@ FQGY\'O:]M)E+-I4+XM:F4Z1JHRD=6/@CJC<;[R-"5%#);1U89
MW<ADD8$P[K,CTEMAF%GWQ$2J+.]/0/+4MF8*)NU@:D(7RWKZ?H!AOIP3QJSG
M>')HELTY!"3:Z=-<X?@1)J]]CP4% :P,B!12%\;:_T][?;WANQW$,BEDP9W'
M.3P-";;['*7 ;(M-^\4FJ9DG"']\Z4J<.CIC;11-3#$1W(X:J5PAIV/@[:!$
M%'U+0YON#F#*;'AA'FD&I_HJUQ;M[:+LJ*00F:K$1<6O!8Z'Y\.V1C2G"N.%
MR0RG/J>>*)F5IFK;FGS)KU0IJ';0:-1P.@C(7#&IL!J6!&2AT9*<6_.4VV,P
M :4@O=\DX:C9W"E.K1KRFM^860>':FJ'ZQVGTU-A[8FJ2VG/J,/3] ;/9IAU
ML0>*\AY.5:M?87W>.74@KBZN(X8=M@MOL+EKP C3>"JMHJ:ZD(H^'9OWWK'I
M WK%2W1Z@Y?X<R'MB:M/:\^PP_:S-]C<6LJMRM#=$%,,7;G Z6+=E>F9:XU_
M"%5=I"?9=X _> ;XCG%X7&1C4.?1W-55'=VN5\?ITC-.([KJI9@&-F&;&]37
M0#L:I.H$CQK?XFS6/</925-,LMY^X'TRQ.>A+ U0=8REIAW"V$^$7?SZI$9R
M*5X%<%?N";Y=RPZ>/S?@A:[DU_$GU5?RF=G=P]<0/(CA"<8#WXZE;W?KV_[T
MI3:4_\GFYR]-RR-XPG'/M:/HS\V[G4\Z"N@YW(J:ZI(J^G1LWGG#QOX=POLS
M*<Z\23C459?1H5?'R9]-EM_1GP'1E5FV$-LULCX5UA%Q=8D=,>RP^;/),I2<
M)<PP,7W B[%BUMIIS,J4U056YM;1\F?'I*_ #CG U5*^(6O_RE1/D\GIT^)+
M$:I+[R77CJ(_^RE[O>EIO0#U[UF6Q/&&:(GW+=<+?S96AI LK,6X,1XQPT]>
M2A[JJLOMT*OCY,_NR4A1^\#5<)V-Y<F7NSU1=0GM&75X_-D?<4/L=I7,J)C"
M.0^5E&NK"ZO<KV/FVS[(;09JBF/ODY)+,\/Y?4[%F<\N' E178(OVG8@_X>M
MD*OH(#7W6&"?G]P<L6_V:4 L^1M02P$"% ,4    " !Z>%U8AY=7%R\/  "[
M:0  #@              @ $     9#<W-CDR-V0X:RYH=&U02P$"% ,4
M" !Z>%U8]<F87)X0   T/   $0              @ %;#P  9#<W-CDR-V1E
M>#$P,2YH=&U02P$"% ,4    " !Z>%U89YS%FCH3  "S2P  $0
M    @ $H(   9#<W-CDR-V1E>#$P,BYH=&U02P$"% ,4    " !Z>%U8#JT<
M&/X0  #K/0  $0              @ &1,P  9#<W-CDR-V1E>#$P,RYH=&U0
M2P$"% ,4    " !Z>%U8&-\K@VD1   W00  $0              @ &^1
M9#<W-CDR-V1E>#$P-"YH=&U02P$"% ,4    " !Z>%U844 -Q@T1   R/@
M$0              @ %65@  9#<W-CDR-V1E>#$P-2YH=&U02P$"% ,4
M" !Z>%U81-0L!&P1  #700  $0              @ &29P  9#<W-CDR-V1E
M>#$P-BYH=&U02P$"% ,4    " !Z>%U8LNRB8SD1  #S.   $0
M    @ $M>0  9#<W-CDR-V1E>#$P-RYH=&U02P$"% ,4    " !Z>%U8^IIM
M-H81  #M.@  $0              @ &5B@  9#<W-CDR-V1E>#$P."YH=&U0
M2P$"% ,4    " !Z>%U8W)#-$'@1  "'.@  $0              @ %*G
M9#<W-CDR-V1E>#$P.2YH=&U02P$"% ,4    " !Z>%U8 ]()JT,#  !9"P
M#P              @ 'QK0  9W0M,C R-# R,C8N>'-D4$L! A0#%     @
M>GA=6 (.IK1@!@  OT,  !,              ( !8;$  &=T+3(P,C0P,C(V
M7VQA8BYX;6Q02P$"% ,4    " !Z>%U8T;W[T+L$  "'*@  $P
M    @ 'RMP  9W0M,C R-# R,C9?<')E+GAM;%!+!08     #0 - #(#  #>
%O      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>d776927d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="gt-20240226.xsd" xlink:type="simple"/>
    <context id="duration_2024-02-26_to_2024-02-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000042582</identifier>
        </entity>
        <period>
            <startDate>2024-02-26</startDate>
            <endDate>2024-02-26</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2024-02-26_to_2024-02-26"
      id="Hidden_dei_EntityRegistrantName">GOODYEAR TIRE &amp; RUBBER CO /OH/</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2024-02-26_to_2024-02-26" id="ixv-312">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-02-26_to_2024-02-26"
      id="Hidden_dei_EntityCentralIndexKey">0000042582</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2024-02-26_to_2024-02-26" id="ixv-323">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-02-26_to_2024-02-26" id="ixv-324">2024-02-26</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-02-26_to_2024-02-26" id="ixv-325">OH</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-02-26_to_2024-02-26" id="ixv-326">1-1927</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-02-26_to_2024-02-26" id="ixv-327">34-0253240</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-02-26_to_2024-02-26" id="ixv-328">200 Innovation Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-02-26_to_2024-02-26" id="ixv-329">Akron</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2024-02-26_to_2024-02-26" id="ixv-330">OH</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-02-26_to_2024-02-26" id="ixv-331">44316-0001</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-02-26_to_2024-02-26" id="ixv-332">(330)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-02-26_to_2024-02-26" id="ixv-333">796-2121</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-02-26_to_2024-02-26" id="ixv-334">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-02-26_to_2024-02-26" id="ixv-335">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-02-26_to_2024-02-26" id="ixv-336">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-02-26_to_2024-02-26" id="ixv-337">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2024-02-26_to_2024-02-26" id="ixv-338">Common Stock, Without Par Value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2024-02-26_to_2024-02-26" id="ixv-339">GT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2024-02-26_to_2024-02-26" id="ixv-340">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-02-26_to_2024-02-26" id="ixv-341">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
